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7ABSTRACT
Material and ﬁ xation properties, and tissue response to biodegradable self-reinforced (SR) 
polylactic acid stereocopolymer implants in the ﬁ xation of diaphyseal osteotomies and 
fractures were examined. Rods and nails made of a poly-L/D-lactic acid stereocopolymer 
with a L/D lactide molar ratio of 96/4 (SR-PLA96) were studied in vitro, subcutaneously 
or intramedullarly (IM) in the experimental studies (I-III). In the clinical study (IV), plates 
made of a poly-L/D-lactic acid stereocopolymer with a L/DL isomere ratio of 70/30 [SR-
PLA (70/30)] were employed.
Based on the in vitro and in vivo studies, the stereocopolymer SR-PLA96 rods showed 
faster degradation and comparable or even higher strength values and strength retention 
than pure SR poly-L-lactic acid rods. Bending and shear strength values stayed above those 
of cortical bone for 24 weeks. Strength properties of the SR-PLA96 rods were deemed 
adequate for ﬁ xation of cortical bone osteotomies in rabbits.
The SR-PLA96 rods were found suitable for ﬁ xation of femoral diaphyseal osteotomies in 
rabbits and solid SR-PLA96 nails interlocked with metallic K wires showed potential in 
sheep.  Uneventful ﬁ xation/healing of femoral diaphyseal osteotomies occurred in 36/43 
(84%) rabbits and in 5/6 (83%) sheep. Biocompatibility of the rods was very good in rab-
bits, even during end-stage degradation at 3 years, when the SR-PLA96 rod had almost 
completely disappeared from the femoral medulla. In sheep, the large SR-PLA96 nail in-
duced only a mild histological reaction at 6-18 months, when the implant was macroscopi-
cally still intact. However, in one sheep at 3-years, an almost disintegrated nail and a con-
siderable but controlled foreign body reaction (FBR) to the implant without an inﬂ amma-
tory component were seen. Premature fragmentation of the implant in nonunions induced 
a FBR both in rabbits and in sheep.  The long-term tissue response to large IM nails should 
be studied in a larger population before these implants are taken into clinical use.
Amorphous SR-PLA (70/30) plates together with metallic miniscrews and light external 
coaptation were deemed suitable for ﬁ xing radial/ulnar fractures in toy breed dogs as 10/11 
(91%) fractures healed within 4-14 weeks without malpositions. Stacked plates were used 
in 6/11 cases to gain more stiffness. Healing and complication rates after repair of radial 
fractures with SR-PLA (70/30) plates were considered similar or better than reported after 
repair with metallic plates or external ﬁ xation in toy breed dogs. No radiographic signs of 
osteopenia were identiﬁ ed under the plate during follow-up. Biodegradable polylactide 
plates could be considered as an alternative to metal plates for radial fracture repair in toy 
breed dogs, however available plates are likely not strong enough when used as a single 
plate.
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1. INTRODUCTION
The ﬁ rst reports on the use of polylactic acid (PLA) implants for ﬁ xation of fractures or 
osteotomies in maxillofacial surgery were published in 1971 by Cutright et al. and Kulkar-
ni et al. Since then, PLA implants have been used both experimentally and clinically in 
ﬁ xations of cancellous bone (Cutright and Hunsuck 1972, Gerlach and Eitenmüller 1987, 
Leenslag et al. 1987a, Suuronen 1991, Bucholtz et al. 1994, Pihlajamäki et al. 1994a,b, 
Koskikare et al. 1996, Partio et al. 1997, Kallela et al. 1999a,b,c). However, the ﬁ xation 
of weight-bearing cortical bone has been infrequent due to problems in strength charac-
teristics of PLA implants - both initially and later regarding strength retention during the 
healing period.
Fixation of fractures with biodegradable implants has many advantages compared with tra-
ditional metallic implants. The implant provides adequate ﬁ xation during fracture healing 
and is absorbed slowly. The stresses are gradually shifted over to the healing bone, which 
reduces risk of osteoporosis and stimulates both bone growth and remodeling (Viljanen 
et al. 1998, 2001). Biodegradable implants have been extensively studied in animal tests 
but most often with human applications in mind (Törmälä 2001). Their clinical use in 
veterinary medicine has been sparse, probably due to their relatively high cost compared 
with metallic implants. However, as no removal operation is necessary with absorbable im-
plants, the higher purchase price is often offset by these savings, and the risks and distress 
associated with the removal operation can be avoided.
Production of devices with initial strength values comparable with those of steel became 
possible after Törmälä et al. (1988,1990) introduced the self-reinforced (SR) structure of 
biodegradable implants, where the matrix is reinforced by ﬁ bers of the same substance. 
Intramedullary rods made of self-reinforced poly-L-lactic acid (SR-PLLA) have been suc-
cessfully used in ﬁ xations of diaphyseal fractures and osteotomies in small animals such 
as rabbits, small dogs, and cats (Majola et al. 1992b, Miettinen et al. 1992a,b, Räihä et al.
1992, 1993c, Manninen and Pohjonen 1993, Viljanen et al. 1998). However, the complete 
degradation and resorption of PLLA material in vivo seem to proceed quite slowly. In 
some studies, PLLA material has totally disappeared from cancellous bone between 2 and 
6 years (Pihlajamäki et al. 1992, Matsusue et al. 1995), but several studies have shown 
PLLA material to exist or to only be partly degraded in the operated area up to ﬁ ve years 
or longer (Bergsma et al. 1995b, Böstman et al. 1995, Majola 1995). In any case, only a 
few late tissue responses have been seen clinically in man during the degradation of PLLA 
implants, manifested most often by a local painless subcutaneous swelling (Bergsma et al.
1993, 1995b, Eitenmüller et al. 1996, Yoshino et al. 1998, Voutilainen et al. 2002a). Reac-
tions have been triggered by highly crystalline PLLA polymer debris still present in the tis-
sues. Absorbable polymers with a low to moderate degree of crystallinity should therefore 
be favored for medical applications because they enhance degradation and probably also 
diminish the risk for late foreign body reactions.
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A racemic polymer of polylactic acid, poly-DL-lactide (PDLLA), is totally amorphous and 
degrades much faster than PLLA (Kulkarni et al. 1971). The copolymers of L-lactide com-
bined with D- or DL-lactide have also been shown to have more rapid degradation rates 
than 100% pure PLLA, with the rate depending on the monomer ratios (Vert et al. 1981, 
Majola et al. 1991a, Bergsma et al. 1995c,d). Majola et al. (1992b) used sintered SR-PLA 
(60/40) rods, which, although they degraded faster, lacked sufﬁ cient mechanical proper-
ties and strength retention for the ﬁ xation of cortical weight-bearing bones. However, the 
SR-PLA96 and SR-PLA (70/30) copolymers developed by Pohjonen and Törmälä (1996) 
have similar initial strength and strength retention in vitro as the SR-PLLA material. These 
self-reinforced polylactic acid stereocopolymer materials with amorphous to moderately 
crystalline morphology also degrade faster than SR-PLLA in vitro.
A femoral fracture is the most common diaphyseal fracture requiring surgical interven-
tion both in animals and humans (Phillips 1979, Böstman and Rokkanen 1986, Unger et
al. 1990). Optimal healing is best ensured by internal ﬁ xation, which is frequently done 
by metallic intramedullary (IM) nailing with or without interlocking (Brinker et al. 1990, 
Brumback 1996). Interlocking is usually necessary for healing of the femoral cortex in un-
stable fractures or in osteotomies with rotational instability (Eveleigh 1995). Radial/ulnar 
fractures are also common in dogs, representing 22% of all long bone fractures (Unger et
al. 1990). Toy breed dogs are particularly prone to these fractures, even after minimal trau-
ma. Fixation of radial/ulnar fractures in toy breed dogs has many potential problems. Os-
teopenia is more often seen in these dogs after external coaptation or ﬁ xation with metallic 
implants with a high bending modulus compared with bone, which can make estimation of 
appropriate time for implant removal difﬁ cult (Waters et al. 1993, Larsen et al. 1999, Haas 
et al. 2003). Skin problems, delayed union, malunion, non-union, and refracture after plate 
removal are not uncommon when treating these fractures in toy breed dogs (Vaughan 1963, 
Sumner-Smith 1974, Hunt et al. 1980, Lappin et al. 1982, Atilola and Sumner-Smith 1984, 
Waters et al. 1993, Muir et al. 1997).
The aim of the present study was to examine the suitability of SR-PLA96 rods and nails 
for ﬁ xation of cortical bone osteotomies in small (rabbits) and large (sheep) adult animals. 
Implant degradation and biocompatibility were also evaluated. A novel way of interlocking 
a biodegradable IM nail was explored. Furthermore, the suitability of totally amorphous 
biodegradable SR-PLA (70/30) plates for ﬁ xation of clinical radial/ulnar fractures in toy 
breed dogs was investigated.
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2. REVIEW OF THE LITERATURE
2.1. Polylactide
2.1.1. Chemical properties
Polylactic acid (PLA) is a hard, pale-colored, linear polymer with thermoplastic proper-
ties. Semi-crystalline PLA (molecular weight over 100 000 daltons) has a glass transition 
temperature (T
g
) of 57-58˚C and a melting point (T
m
) of 174-184˚C (Vert et al. 1981,1984, 
Hollinger and Battistone 1986, Törmälä et al. 1998).
Most polymers are macromolecules composed of many repeating units (monomers) that 
have carbon atom backbones. The reaction that produces a polymer from a monomer is 
known as polymerization. When identical monomers react, a homopolymer is formed, 
whereas a combination of two different monomers can produce a random copolymer (-
AABABBBAAABABA-), a block polymer (-AAAAA-BBBBB-AAAAA-), or a graft 
polymer (- AAAAA- backbone with -BBBBB groups attached) (Hollinger and Battistone 
1986, Pietrzak et al. 1997).
Monomeric lactic acid belongs to the group of alpha–hydroxy acids. A lactic acid molecule 
is chiral, i.e. has two enantiomeric forms, L and D, with similar intrinsic chemical proper-
ties but opposite conﬁ gurational structures. The cyclic diester of lactic acid is called lac-
tide. Lactide exists as four different compounds: the LL and DD antipodes (L-lactide, i.e.
levolactide, and D- lactide, i.e. dextrolactide, respectively), the DL isomer (mesolactide), 
and the DD+LL solid combination (racemic lactide) (Vert et al. 1981) (Fig. 1). Monomeric 
L-lactic acid can be produced from molasses and potato starch. It can be found in the car-
bohydrate metabolism of all living organisms and is the end-product of the anaerobic me-
tabolism of glucose. The D-isomer is naturally found in acidic milk. Normal blood plasma 
levels of DL-lactate in man are low, originating from dietary intake and colonic bacterial 
fermentation (Brandt et al. 1980, Uribarri et al. 1998).
H O
O
H
CH3O
O
CH3
CH3
O
O
CH3
HO
O
H
H O
O
CH3
HO
O
CH3
L-lactide D-lactide
DL-lactide
i.e. mesolactide
H O
O
H
CH3O
O
CH3
CH3
O
O
CH3
HO
O
H
rac-lactide
O- C- CO ]
CH3
H
[ O- C- CO
CH3
H
H
PLA stereocopolymer
= PLAX
[X= 100n /(n+p)]
PLA homopolymer
= PLA100
L-lactic D-lactic
Amorphous if L/D molar ratio 
(n/p) < 87.5/ 12.5
[ O- C- CO ]n
CH3
n p
Fig. 1. Four stereoisomers of lactide Fig. 2. Structure of polyactides
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Poly-L-lactic acid, i.e. PLLA, consists of only the L-isomer. The polylactic acid stereo-
copolymers, which contain both isomers, are usually named by the relative amount of 
L-lactic acid compared with D-lactic acid, e.g. PLA96 (= poly-96L/4D-lactic acid = poly-
92L/8DL-lactic acid = PLA (92/8)), or the ratio of L and DL isomers is reported, e.g. PLA 
(70/30) (= poly-L70/30DL-lactic acid = poly-85L/15D-lactic acid = PLA85). The relative 
amounts of L- and D-conﬁ gurations affect the physical and chemical properties of these 
stereocopolymers (Fig. 2).
PLLA contains a methyl group that makes it hydrophobic and thus quite resistant to hydro-
lysis. Racemic poly-DL-lactide does not form crystals like PLLA, resulting in weaker and 
more rapidly degrading implants. Crystallinity results in birefringence when exposed to 
polarized light, and conversely, amorphous polymers exhibit no response to polarized light 
(Kulkarni et al. 1971, Vert et al. 1981, Majola et al. 1991a, Pietrzak et al. 1997).
The ring-opening polymerization of lactide cyclic diesters is an efﬁ cient method for pro-
ducing high molecular weight (HMW) polymers. The resulting PLLA is a highly crystal-
line polymer, whereas PDLA and stereocopolymers with a molar ratio of L/D less than 
87.5/12.5 are intrinsically amorphous (Vert et al. 1981, 1984, 1986, Andriano et al. 1994). 
Because D-lactide closely resembles the reactivity of L-lactide, copolymerization of these 
monomers results in a random copolymer. Thus, by increasing the amount of D-lactide, a 
greater disorder of L-lactide sequences occurs in the copolymer, resulting in a decrease in 
crystallinity and melting temperature (Andriano et al. 1994).
2.1.2. Biodegradation
Biodegradation of PLA occurs mainly by hydrolysis (nonspeciﬁ c hydrolytic scission). 
Polylactic acid undergoes hydrolytic de-esteriﬁ cation to lactic acid, which becomes in-
corporated in the citric acid cycle and is excreted predominantly by the lungs as carbon 
dioxide and water (Brady et al. 1973, Hollinger and Battistone 1986, Jamshidi et al. 1986, 
Cordewener et al. 1995). The presence of certain enzymes has also been shown to hasten 
the degradation of PLA in vitro. Pronase, proteinase K, and bromelain all had signiﬁ cant ef-
fects on the rate of PLA degradation, ﬁ cin, esterase, and trypsin showed a smaller response, 
and lactate dehydrogenase had no effect (Williams 1981). The enzymatic degradation pro-
cess has been suggested to be more extensive at the later stage of the partially hydrolyzed 
polymer (Gogolewski et al. 1993).
Biological behavior (degradation, loss of strength, biocompatibility) of PLA can be affected 
by numerous factors in the history of a polymer implant, which explains why compounds 
with the same name can exhibit dramatically different properties (Vert et al. 1992) (Table 
1). Degradation proceeds ﬁ rst in the amorphous regions of the polymer, followed by the 
crystalline regions. The rate of degradation is slower for polymers of HMW, crystallinity, 
and orientation, large size, nonporous material, and high monomer purity. Homopolymers 
degrade slower than copolymers. Implantation site may affect the degradation rate due 
to differences in tissue vascularity and load-induced stress- cracking. Variability should 
be expected from batch to batch (Kulkarni et al. 1971, Gogolewski 1992, Suuronen et al.
1992, Vert et al. 1992, Pistner et al. 1993b, Zhang et al. 1994, Bergsma et al. 1995c).
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Loss of molecular weight is the ﬁ rst sign of degradation, as hydrolysis splits the chemical 
bonds of long polymers (Reed and Gilding 1981). The rate of molecular weight decrease is 
faster at the beginning of hydrolysis and slower towards the end of degradation (Bos et al.
1989a, Matsusue et al. 1992). Loss of mechanical strength properties precedes changes in 
the macroscopic form of an implant, which is followed by major mass loss and ﬁ nally the 
ingestion of polymer debris by phagocytic cells (Pietrzak et al. 1997, Törmälä 2001).
The complete degradation and resorption of PLLA material in vivo seem to proceed quite 
slowly. The short life expectancy of rats and rabbits, commonly used as experimental ani-
mals, limits the follow-up periods of experimental studies. The total degradation time of 
PLLA implants was originally extrapolated to be around 3-4 years based on experimental 
studies (Rozema et al. 1990, Bos et al. 1991), but several investigators have found PLLA 
material to still be present in the operated area over 4-5 years after surgery (Bergsma et
al. 1995b, Böstman et al. 1995, Majola 1995, Laitinen et al. 2002). SR-PLLA material 
degrades faster in cancellous than cortical bone (Majola 1995). The drill channels of clini-
cal patients receiving implants of ultrahigh strength, drawn PLLA or SR-PLLA could be 
seen in magnetic resonance imaging (MRI) from 3 to even 9 years postsurgery, indicating 
either that the implants had not yet degraded or that the drill channels were not replaced by 
bone after degradation (Matsusue et al. 1997, Pihlajamäki et al. 1997). In a recent report, 
no polarizing material was found in histology when SR-PLLA screws were implanted in 
a sheep femur for ﬁ ve years, but the screw sites were only partly replaced by new bone 
(Jukkala-Partio et al. 2001). Despite numerous experimental studies and clinical use since 
1988, few studies report total or end-stage degradation of PLLA in vivo (Table 2).
Table 1. Factors affecting the degradation of biodegradable polymers (Vert et al. 1992).
Chemical structure
Chemical composition
Distribution of repeat units in multimers
Presence of ionic groups
Presence of unexpected units or chain defects
Conﬁ gurational structure
Molecular weight
Molecular weight distribution (polydispersity)
Presence of low molecular weight compounds (monomer, oligomers, solvents, iniators, drugs, etc.)
Processing conditions
Shape
Sterilizing process
Morphology (amorphous vs. semicrystalline, presence of microstructures, presence of residual stresses)
Annealing
Storage history
Site of implantation
Adsorbed and absorbed compounds (water, lipids, ions, etc.)
Physiochemical factors (shape and size changes, variations of diffusion coefﬁ cients, mechanical stresses, stress and 
solvent-induced crackings, etc.)
Mechanism of hydrolysis (enzymes vs. water)
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The less crystalline stereocopolymers of L-lactide with D- or DL-lactide have faster deg-
radation rates than 100% pure PLLA, with the rate depending on the monomer ratios 
(Christel et al. 1983, Bergsma et al. 1995c,d), although also initially amorphous PLA does 
crystallize to some extent as degradation proceeds (Li et al. 1990, Andriano et al. 1994, 
Pohjonen and Törmälä 1996). Bergsma et al. (1995d) calculated from mass-loss studies of 
PLA and PLA96 that the incorporation of 4% D-lactide would enhance the degradation rate 
by a factor of two, and predegraded PLA96, implanted subcutaneously in rats, did show 
enhanced degradation compared with predegraded PLLA. Some studies reporting total in
vivo degradation of stereocopolymer implants are shown in Table 2. Complete degradation 
of amorphous SR-PLA (70/30) is expected to take 2-3 years, as extrapolated from in vitro
hydrolysis studies (Pohjonen and Törmälä 1996). When SR-PLA (70/30) screws of 3.5 mm 
outer diameter were used to ﬁ x mandibular body osteotomies in sheep, some cracks, clefts, 
and fragmentation were seen in screws after 24 weeks, but the material otherwise seemed 
morphologically unchanged (Kallela et al. 1999c).
2.1.3. Mechanical properties and manufacturing
A safe bioabsorbable implant should have high initial strength, appropriate initial modulus 
(comparable with the tissue of implantation), and controlled strength and modulus reten-
tion in vivo. Some initial strength values of different polymer implants, steel, and cortical 
bone are shown in Table 3. Several factors contribute to degradation of polymer implants 
in living tissues and thus also to strength retention. Any quantitative evaluations should be 
Polymer Fixation/implantation Implant size Degradation time Species Reference
PLLA Plate and screws to ﬁ x 
mandibular fractures
- 40 weeks Canine Getter et al. 1972
SR-PLLA Pins to ﬁ x small 
fragment cancel-
lous bone fractures 
and osteotomies
1.5-2.0 mm 20 and 37 months Human Pihlajamäki et al. 1992
Ultrahigh
strength
PLLA
Rods implanted 
subcutaneously
and in femur
3.2 mm 5-6 years Rabbit Matsusue et al. 1995
SR-PLLA Plates to ﬁ x cranioto-
my lines
0.5 mm 2 years Ovine Peltoniemi et al. 1998
SR-PLLA Multilayer plates to 
ﬁ x mandibular oste-
otomies
0.5 mm
x 4
5 years Ovine Suuronen et al. 1998
SR-PLLA Screws implanted in 
femur
6.3 mm 5 years Ovine Jukkala-Partio et al. 2001
PLA96 Plates to ﬁ x calvarial 
osteotomies
0.4 mm 2 years Ovine Peltoniemi et al. 1999b
SR-PLA
(60/40)
Rods intramedullary 
to ﬁ x cortical osteoto-
mies
4.5 mm 4.5 years Rabbit Majola 1995
PDLLA Screws to ﬁ x ACL 
reconstruction
arthroscopically
- 10-12 months Human Stähelin et al. 1997
PDLLA Rods to ﬁ x man-
dibular fractures
1/8´´ 8 months Canine Kulkarni et al. 1971
Table 2. Studies reporting end-stage degradation of polylactide implants in vivo.
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done only in samples, in which the physicochemical parameters (e.g. molecular weight, 
molecular weight distribution, monomer content, porosity, size of implant) are identical. 
Poor characterization of these parameters in many studies makes reliable comparison dif-
ﬁ cult and also explains the wide variation of strength retention values for the same polymer 
(Törmälä et al. 1998). Loss of strength has been faster in vivo than in vitro in many studies 
(Bos et al. 1988, Suuronen et al. 1992, 1998, Pohjonen et al. 1997b).
For safe fracture ﬁ xation, it has been proposed that the strength of an implant exceed the 
strength of cortical bone (Törmälä et al. 1998). Strength values of nonreinforced bioab-
sorbable polymers made by traditional melt molding techniques, like extrusion and injec-
tion molding, are typically 40-140 MPa, thus being inferior to those of cortical bone. The 
size of these implants is often quite large due to lower strength values and brittleness, 
making them less suited for clinical applications (Törmälä 2001). In general, incorpora-
tion of D-lactide units into L-lactide reduces the mechanical properties of PLA. Among 
nonreinforced polymers, only PLLA and stereocopolymers with L>92% have been stated 
to have acceptable initial mechanical properties and strength retention to allow synthesis of 
reasonably stressed bone fractures (Vert et al. 1984, 1992, Gerlach et al. 1987).
The self-reinforcement (SR) technique, which was used to manufacture implants in this 
study, can multiply the strength properties of polymer implants. In this technique, the 
polymeric matrix is reinforced with oriented, ﬁ brous reinforcement elements that have 
the same chemical composition as the matrix. The most effective way to create the SR 
structure in a biodegradable nonreinforced polymer is mechanical deformation. Different 
modes of deformation, such as free drawing, die drawing, oven drawing, zone annealing, 
rolling, sintering, and ﬁ brillation, are possible, resulting in different kinds of microstruc-
ture. However, a feature common to all deformation processes is the induction of oriented, 
self-reinforced structures into the polymeric matrix. The SR method can also be applied 
to amorphous polylactides. High molecular weight and increasing the draw ratio up to a 
critical point will increase the ﬁ nal strength and modulus of SR composites (Törmälä et al.
Material Bending 
strength
(MPa)
Shear
strength
(MPa)
Torsion strength
(MPa)
Bending
modulus
(GPa)
Molecular
weight
(g/mol)
Crystallinity
%
Refer-
ence
PLLA 113-142 49 2.1-5.1 31 000 62 1,5
Drawn PLLA 160-270 5-17 220 000 6
SR-PLLA 177-300 100-200 45-49 MPa
Max torque 0.2 Nm
6-15 44-61 000 53-69 3,7
PLA95 and 
PLA 97.5 
87-112 47 2.1 17-27 000 23-38 1
SR-PLA96 210 151 7.5 37 7
SR-PLA 90 174 108 6 8 7
SR-PLA85 163-170 110-116 Max torque 0.14 Nm 5-6 42 000 0 3,7
Stainless steel 400 Max torque 2.3 Nm 100-200 2,4
Cortical bone 180-195 60-90 5-29 2,4
1 =Gogolewski and Mainil-Varlet 1997; 2=Räihä et al. 1992; 3= Pohjonen et al. 1997b ,Pihlajamäki et al. 1997, Majola et al. 1992a, Manninen and 
Pohjonen 1993; 4= Tonino et al. 1976, Swanson 1971; 5= Gerlach and Eitenmüller 1987, Bos et al. 1989a,b; 6= Yamamuro et al. 1994, Hanafusa et al. 
1995, Matsusue et al. 1991; 7= Pohjonen and Törmälä 1997a
Table 3. Initial mechanical properties of different polylactide implants, cortical bone, and steel. 
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1988, 1990, 1992, 1998) (Fig.3).
Only a few reports exist of PLA implants with sufﬁ cient strength values and strength re-
tention to be considered for use in ﬁ xation of weight-bearing diaphyseal bones. Reported 
strength values and retention of polylactide and stereocopolymer implants used in the cor-
tical area are shown in Table 4. Both initial strength values and strength retention of SR-
PLLA implants have been measured to be adequate even for ﬁ xation of uncomplicated 
weight-bearing osteotomies. Of the nonreinforced polylactide implants, only the uniaxially 
drawn, ultrahigh strength PLLA rods and screws have shown sufﬁ cient initial bending 
strength values. These implants are also produced by a drawing method that does not, 
however, produce the ﬁ brillating microstructure (Matsusue et al. 1991, Yamamuro et al.
1994).
Strength loss of PLA stereocopolymers is usually faster than that of pure PLLA. Corde-
wener et al. (1995) studied nonreinforced PLA96 and reported a complete loss of mechani-
cal properties of subcutaneous implants after just seven weeks. However, many self-rein-
forced stereocopolymers, e.g.. SR-PLA96, SR-PLA90, and SR-PLA (70/30), have exhib-
ited high initial strength values and the capability of retaining initial strength properties for 
12-30 weeks in vitro. Both SR-PLA96 and SR-PLA (70/30) retained their original bending 
strength for 18 weeks and original shear strength for 24 and 12 weeks in vitro, respectively 
(Pohjonen and Törmälä 1997a). Joukainen et al. (2000) reported high initial strength val-
ues and strength retention of SR-PLA (70/30) rods in vivo after subcutaneous implantation 
and ﬁ xation of distal femoral osteotomies in rats (Table 4).
SR-PLA
PLA
M
F
A
B
Fig. 3.
A) Transformation of a nonreinforced polymer billet (PLA) into an oriented self-reinforced form (SR-PLA).
B) Schematic illustration of the structure of a self-reinforced bioabsorbable composite consisting of a matrix (M) reinforced with
parallel, oriented reinforcing elements (F)
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2.1.4. Biocompatibility
The ﬁ nal biocompatibility of an absorbable implant is revealed only when the material 
has totally disintegrated. This can take many years with PLA implants, depending largely 
on the monomer ratios. The following studies are therefore divided into those with a short 
(less than one year) and those with a long (more than one year) follow-up.
2.1.4.1. Experimental studies
Experimental studies with a short follow-up
The biocompatibility of PLLA and its stereocopolymers has been found to be very good 
in many experimental studies with short follow-up times. These follow-ups document the 
biological response to the still predominantly intact implant. No clear foreign body reac-
tions (FBR) have been reported in these studies where the material has been implanted 
subcutaneously, implanted inside the bone, or used to ﬁ x different osteotomies. Histology 
has been investigated in rats (Vert et al. 1984, Majola et al. 1991a, Gogolewski et al. 1993, 
Bergsma et al. 1995d, Koskikare et al. 1998, Nordström et al. 1998, Joukainen et al. 2000), 
in rabbits (Majola 1991b, Matsusue et al. 1992, Manninen and Pohjonen 1993, Pihlajamäki 
et al. 1994c, Hanafusa et al. 1995, Koskikare et al. 1996), in sheep and goats (Vert et al.
1984, Bos et al. 1989b, Rozema et al. 1990, Laitinen et al. 1993, Kallela et al. 1999c), 
in pigs (vd Elst et al. 1995), in cats (Hara et al. 1994b), in dogs (Eitenmüller et al. 1987, 
Leenslag et al. 1987a, Bos et al. 1989a, Miettinen et al. 1992b, Hara et al. 1994a), and in 
monkeys (Cutright and Hunsuck 1972). After the initial inﬂ ammatory reaction to the surgi-
cal trauma has diminished, the histology generally shows only a mild grade inﬂ ammation. 
Small amounts of macrophages, histiocytes, foreign body giant cells, and lymphocytes are 
usually seen near the implant. Occasional mast cells, eosinophils, and plasma cells have 
Table 4. Reported strength retention of polylactide implants used on cortical areas
(BS= bending strength, SS= shear strength, BM= bending modulus).
Polylactide Implant Initial strength 3 weeks 6 weeks 12 weeks 24-25
weeks
36
weeks
Reference
Ultrahigh
strength
PLLA
Rod
(in vitro)
BS 220 MPa
BM 13 GPa
132 MPa 0 Matsusue 
et al. 1991
Sintered
SR-PLLA 
Rods
(in vivo)
BS 250-271 MPa
SS 94-98 MPa
196 MPa 115 MPa 100 MPa
94-98 MPa 27 MPa
10-20
MPa
Majola et
al. 1992a
Fibrillated
SR-PLLA
Rods
(in vivo)
BS 245 MPa
SS 136 MPa
BM 8.2 GPa
129 Mpa
5.9 GPa
245 MPa
115 MPa
5.5 GPa
32 Mpa 10 MPa
Manninen
and Poh-
jonen 1993
SR-PLA 
70/30
Rods
(in vivo)
BS 214 MPa
SS  121 MPa
BM 6 GPa
195 Mpa
118 Mpa
5.7 GPa
170 MPa
115 Mpa
3.8 GPa
Joukainen
et al. 2000
Sintered SR-
PLA 60/40
Rods
(in vivo)
BS 209 MPa
SS 102 MPa
123 MPa
102 MPa
17 MPa
47 MPa
0
0
Majola et 
al. 1992a
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also been reported but no accumulations of inﬂ ammatory cells. A thin ﬁ brous capsule typi-
cally forms around the implant, which is later surrounded by a small rim of bone tissue. 
Van der Elst et al. (1995) reported that the tissue reaction to PLLA in young pigs was quite 
similar to the one induced by stainless steel controls.
However, when Räihä et al. (1990) used Ø 4.5 mm SR-PDLLA/PLLA (50/50) screws to 
ﬁ x trochanteric osteotomies in beagles, 2/6 dogs developed cysts of clear ﬂ uid around the 
screw heads within 7-8 weeks. Aerobic culture was negative, but the cellular analysis was 
not discussed in the paper. Furthermore, when femoral cortical osteotomies in cats were 
ﬁ xed by stack pinning with Ø 2 mm SR-PLLA rods, 2/4 cats showed a bone loss defect in 
the lateral cortex at the site of the osteotomy at 24 weeks. Macrophage-type foam cells and 
polynuclear giant cells containing polarizing ﬁ brous elements were seen in histology in all 
cats, but a slight neutrophil inﬁ ltration was observed only at the defects. Possible explana-
tions included infection, pressure necrosis from the rods, thermal necrosis from creating of 
osteotomy, or a sinus reaction due to a FBR (Räihä et al. 1992).
Experimental studies with a long follow-up
Many longterm experimental studies of PLLA with times ranging from 2 to 5 years have 
shown good biocompatibility. Investigations have been done in rats (Bos et al. 1991, Ma-
jola 1995), in rabbits (Majola 1995, Matsusue et al. 1995,), and in sheep (Christel et al.
1984, Peltoniemi et al. 1998, 1999a, Suuronen et al. 1998) with implantations being sub-
cutabeous or intramedullary, on top of or inside bone. The studies on SR-PLLA implants 
have reported a mild FBR where a connective tissue envelope with a limited number of 
phagocytic foamy macrophages and foreign body giant cells are seen around the implant 
material during the ﬁ nal degradation stages. On only a few occasions have lymphocytes 
been reported. Matsusue et al. (1995) described that phagocytosis by mononuclear histio-
cytes without giant cell involvement as the main characteristic of degradation with drawn, 
ultrahigh strength PLLA implants.
Bos et al. (1991) implanted as-polymerized PLLA plates subcutaneously and reported a 
rather acellular ﬁ brous capsule around the implant up till two years. However, after that, a 
foreign body reaction with abundant foamy macrophages but no giant cells was seen in the 
only rat that survived for 2.75 years. Another experimental study with a more pronounced 
tissue reaction has been reported by van der Elst et al. (1998, 1999). They compared HMW 
as-polymerized PLA, PLA/PGA (20/80), and steel interlocked nails (130 mm, Ø 12 mm) 
in ﬁ xation of complete midshaft femoral osteotomies in 21 sheep. After 2.5 years, a severe 
FBR accompanied by an inﬂ ammatory reaction against both biodegradable materials was 
seen. The implants were encapsulated by a ﬁ brous layer containing many multinuclear 
cells and ﬁ broblasts, and also many lymphocytes were seen around the PLA nail. The 
PLA/PGA compared with PLA showed a more severe FBR, with many multinuclear cells 
and cells of the mononuclear phagocytosis system, such as lymphocytes and plasma cells, 
being present. With both polymer materials, the FBR was more pronounced when implant 
material was more disintegrated. The authors concluded that this reaction could imply cer-
tain risks for repulsion. However, these microscopic ﬁ ndings were not accompanied by any 
obvious clinical signs of illness in the sheep.
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Simulated long-term tissue response has also been investigated with predegraded implant 
material. Van der Elst et al. (1996) studied the tissue responses when predegraded as-po-
lymerized PLLA powder was implanted IM after ﬁ xation of partial femoral shaft osteoto-
mies in two young pigs with interlocked PLLA nails (Ø 12 mm). Only a mild inﬂ ammatory 
tissue response consisting of multinuclear giant cells and ﬁ brous tissue accompanied by 
some macrophages, lymphocytes, plasma cells, and granulocytes was seen. Rozema et al.
(1991) implanted predegraded HMW as-polymerized PLLA subcutaneously in rats. The 
tissue response consisted of ﬁ broblasts, histiocytes, and lymphocytes. Internalized PLLA 
was seen inside some macrophages and occasional giant cells, but no foamy macrophages 
were found.
As PLLA implants are present in the tissues for a long time, the tumorigenicity of the im-
plants has been investigated in rats. When PLLA blocks (3x3x2 mm) or plates (20x10x1 
mm) were implanted subcutaneously for two years in two studies, no signiﬁ cant difference 
between the incidence of tumors caused by PLLA versus medical-grade polyethylene was 
seen. The sarcomas induced during implantation were accredited to the Oppenheimer ef-
fect, in which the long-term implantation in rodents induces foreign body tumorigenesis 
independent of the chemical nature of the implants (Pistner et al. 1993a, Nakamura et al.
1994). In vitro, PLA has even been observed to inhibit carcinoma cell growth (Campbell 
et al. 1994).
Only a few experimental long-term studies of PLA stereocopolymers in bone ﬁ xation have 
been published. Majola et al. (1995) reported that the ﬁ nal degradation of femoral in-
tramedullary SR-PLA (60/40) rods in rabbits and screws in rats induced a very mild reac-
tion in bone between 3 and 4.5 years. No major foreign body reaction occurred, and the 
amount of phagocytic cells (foamy macrophages) was even less with the SR-PLA (60/40) 
than with SR-PLLA. Peltoniemi et al. (1999b) observed a thin ﬂ uid layer containing active 
giant cells, macrophages, lymphocytes, and plasma cells around a thin SR-PLA96 plate at 
0.5-1 year. After two years, the plate had disappeared, and no signs of a FBR were seen 
on the smooth bone surface. Bergsma et al. (1995c,d) implanted predegraded as-polymer-
ized PLLA and PLA96 subcutaneously in rats. PLA96 showed enhanced degradation with 
abundant foamy macrophages internalizing the disintegrating particles, whereas PLLA in-
duced only a mild FBR of the still quite inert material at 80 weeks.
2.1.4.2. Clinical studies
Clinical studies with a short follow-up
Many clinical studies in dogs, cats, or man with short follow-ups have shown no clinical 
complications due to the biodegradable SR-PLA material (Partio et al. 1992, Räihä et al.
1993a,b,c, Pihlajamäki et al. 1994a,b, Kallela et al. 1999a).
A clinical follow-up of a stereocopolymer implant was reported by Stähelin et al. (1997), 
who arthroscopically detected no FBR to PDLLA screws used for bone plug ﬁ xation even 
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during their total degradation at 10 months. Suuronen et al. (1999) stated that, because of 
its faster degradation, amorphous absorbable SR-PLA (70/30) plates and miniscrews are 
nowadays exclusively used in clinical craniofacial ﬁ xations at Helsinki University City 
Hospital, with no clinically manifested complications.
Clinical human studies with a long follow-up
Longterm clinical follow-up of PLLA implants in humans has mainly shown good bio-
compatibility, with no clinical signs of a FBR. Follow-up times have varied from 3-9 years 
with the nonreinforced PLLA implants (Cordewener et al. 1996, Matsusue et al. 1997) to 
of 3-8 years with the SR-PLLA implants (Pihlajamäki et al. 1997, Kallela et al. 1999c,
Voutilainen et al. 2001a,b).
Self-limiting osteolytic changes in bone tissue surrounding the PLA implants have been 
reported in 15-27% of patients in two studies. This reaction, which had no effect on the 
clinical course, was considered to be due to accumulation of polymer debris beyond the 
absorptive capacity of bone tissue, with ensuing rises in osmotic pressure inducing oste-
olysis (Matsusue et al. 1997, Kallela et al. 1999c). A local swelling was reported with low 
incidence (in 1/83 and 1/51 patients at 15 and 22 months postoperatively, respectively) 
when PLLA and SR-PLLA screws were used in ankle fractures. Removal of the screw 
resulted in uneventful recovery in one case, in another case the swelling was self-limiting. 
Palpable screws were removed in three and two cases, respectively, during the 3- to 4-year 
follow-ups (Bucholtz et al. 1994, Böstman et al. 1995).
Clinically detectable, late FBRs with nonreinforced PLLA have been reported when rel-
atively bulky extraosseous plates were used in man. Bergsma et al. (1993,1995b) used 
HMW as-polymerized PLLA plates (30x6.7x2 mm) and screws (Ø 2.7 mm) to ﬁ x zygo-
matic fractures. After 3-5 years, 9/10 patients showed FBR without signs of inﬂ amma-
tion, manifested as a painless swelling at the site of implantation. A thin ﬁ brous capsule 
enveloped large areas of foreign body material that consisted of birefringent, needle-like, 
highly crystalline PLLA particles. The material was also seen inside foamy macrophages 
and foreign body giant cells. No signs of major cell death were observed. The histologi-
cal picture did not markedly change from 3.3 to 5.7 years. The swelling was considered 
to be caused by disintegration of the PLLA material into small particles and the increased 
osmotic pressure induced by it in the subcutaneous tissue. Eitenmüller et al. (1996) used 
nonreinforced PLLA plates in ankle fracture surgery of 19 patients and reported swelling 
of the implant site in 52% of patients one year after application. Reducing the size of the 
plates eliminated these adverse tissue reactions. 
The overall complication rate originating from the bioabsorption of SR-PLLA seems to 
be low since complications related to degradation were reported in only 0.1% of the pa-
tients operated on at Helsinki University Hospital between 1988 and 1996 (Rokkanen and 
Törmälä 1996). A recent article reported that no sinus formations and only three ﬂ uid ac-
cumulations (0.3%) were seen when complications of the ﬁ rst 1043 orthopedic and trauma 
operations with SR-PLLA implants were evaluated (Juutilainen et al. 2002).
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2.1.5. Studies of polylactide implants used in the diaphyseal area
Vert et al. (1984) studied a copolymer in which PLA plates were reinforced with PGA 
ﬁ bers on intact and osteomized sheep tibiae. They concluded that, although the degrada-
tion rate of the implant seemed appropriate, the material was not strong enough for the 
manufacturing of long bone plates. Partially degradable PLLA plates reinforced with car-
bon ﬁ ber were used to ﬁ x radial and tibial osteotomies in six German Shepherd dogs by 
Alexander et al. (1981). All 3 radii and 2/3 tibias healed successfully, but when the same 
group used similar composite plates to ﬁ x femoral osteotomies in 8 coonhounds, the plates 
either failed, delaminated, or were too ﬂ exible, producing hypertrophic nonunions in all 
dogs (Zimmerman et al. 1987).
Eitenmüller et al. (1987) were among the ﬁ rst to use totally biodegradable PLLA plates and 
screws in ﬁ xation of radial osteotomies in 12 beagles. A delayed bony union with callus 
formation was observed in most cases.
Miettinen et al. (1992a,b) studied SR-PLLA rods in IM ﬁ xation of femoral shaft osteoto-
mies in 7 rabbits and 6 dogs (aged 12 weeks). Solid union of the osteotomy after 6 weeks 
was seen in both studies, and the rods did not cause any signiﬁ cant disturbance to the lon-
gitudinal growth of the operated femur.
Majola et al. (1992b) was the ﬁ rst to publish a study on a successful application of absorb-
able implants for IM ﬁ xation of weight-bearing cortical bone osteotomies in adult animals. 
Femoral diaphyseal osteotomies of rabbits were ﬁ xed IM with sintered SR-PLLA and SR-
PLA (60/40) rods. A total of 37/40 (93%) of the SR-PLLA ﬁ xations were ﬁ rm, implant 
failure was observed in two cases, and nonunion in one case. The SR-PLA (60/40) ﬁ xations 
were not successful, as only 30/45 (67%) were ﬁ rm; 13/30 (43%) had angulation deform-
ity, and 15 cases of implant failure were seen. Manninen et al. (1993) used ﬁ brillated SR-
PLLA rods in a similar study design in 42 rabbits. No implant failures and only two cases 
of nonunion were seen. Healing of the osteotomy was good in 33 cases and satisfactory 
in 6 cases (altogether 90%). Räihä et al. (1992) ﬁ xed experimental femoral midshaft oste-
otomies in four cats with thin SR-PLLA rods. The stack pinning technique did not prevent 
rotational forces, and all osteotomies healed with slight or moderate angulation or rotation. 
Sutta and Räihä (1990) used one or more ﬁ brillated SR-PLLA rods to ﬁ x experimental 
midshaft femoral osteotomies of 8 dogs (mean 13 kg) with no external support. Only half 
of the dogs did not show implant failure, and even then, there was a tendency for delayed 
union, which was attributed to the rotational instability of the ﬁ xation. 
Tunc (1995) reported using orientruded PLA screws and plates to ﬁ x midshaft femoral 
osteotomies in dogs. Fracture healing was observed radiographically at about 6 weeks, but 
the number, age, and size of the dogs or implants were not revealed in this review article.
Van der Elst et al. (1995, 1998, 1999) used PLLA rods to interlock intramedullary PLLA 
nails in ﬁ xation of femoral osteotomies in 12-week-old pigs (mean weight 35 kg). All 
healed with callus formation. The same operative technique was used when the author later 
compared ﬁ xations with as- polymerized PLLA, PLA:PGA (80:20), and stainless steel IM 
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nails in adult sheep. Most of the femurs showed normal consolidation, but 1/5 PLLA sheep 
and 1/7 PLA:PGA sheep showed some minor bending and shortening of the operated legs. 
Hanafusa et al. (1995) ﬁ xed femoral shaft osteotomies in rabbits with drawn PLLA and me-
tallic plates. The PLLA and stainless steel groups showed union rates of 67% (39/58) and 
80% (28/35), respectively. PLLA plate failure occurred in 14%. The stainless steel group 
showed signiﬁ cantly lower mechanical strength, with the stainless steel ﬁ xation leading to 
osteopenia because of stress shielding after 25 weeks. Hara et al. (1994) used PLLA rods 
to ﬁ x experimental femoral diaphyseal osteotomies in 15 cats (mean weight 1.1 kg, age 5-6 
months). A Thomas splint was used postoperatively to prevent rotational forces. Abundant 
callus formation was seen, but the fracture line disappeared in 8 weeks in these immature 
cats. The same authors studied 1996 piezoelectricity of drawn PLLA by ﬁ xing tibial oste-
otomies of 3- to 4-month-old kittens with drawn and undrawn PLLA rods. Casts were used 
postoperatively and cats lived in cages during healing. They reported promotion of fracture 
healing with increased callus formation as the draw ratio of the PLLA increased. 
Viljanen et al. (1998, 2001) compared cortical bone density changes after IM ﬁ xation of 
distal femoral diaphyseal osteotomies with SR-PLLA and interlocked metallic rods in rab-
bits. Bone changes at the osteotomy site were evaluated by radiography, computed tom-
ography (CT), quantative CT, and MRI. No signiﬁ cant differences in cortical bone density 
were found in the SR-PLLA-ﬁ xed femurs compared with the intact control femurs, but the 
metal-ﬁ xed femurs showed signiﬁ cantly lower density values, indicating stress protection 
by the metallic ﬁ xation.
The only clinical orthopedic ﬁ xations of the cortical area with totally biodegradable PLA 
implants have been reported by Räihä et al. (1993b,c). The SR-PLLA rods were used in 
both weight-bearing cancellous and cortical fractures of cats and dogs. After simple cancel-
lous or physeal fractures of 10 dogs (mean weight 14.2 kg, mean age 16 months) and 9 cats 
(mean weight 3.3 kg, mean age 9 months) were ﬁ xed, external support was usually used for 
2 weeks. The radiological end result was evaluated as excellent or good in 16 cases (84%) 
but the functional end result was judged to be excellent in all but one of the healed cases. In 
another clinical study, IM nailing was used to ﬁ x uncomminuted, closed, diaphyseal frac-
tures of 11 dogs (mean weight 6.5 kg, mean age 15 months) and 14 cats (mean weight 3.7 
kg, mean age 13 months). External bandaging was used for 1-2 weeks, except with radial/
ulnar fractures, where an external splint was used for the whole healing period. Altogether 
92% of cases healed, and the overall result was good or excellent in 72%.
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3. THE PRESENT STUDY
3.1. Aims of the study
Answers to the following questions were sought:
1.  How do the material properties of ﬁ brillated SR-PLA96 rods change during deg- 
 radation in vitro and subcutaneously in vivo in rabbits within a 24-week period?
 Are the strength values and the strength retention of these implants adequate for  
ﬁ xation of diaphyseal osteotomies in rabbits?
2.  Can femoral diaphyseal osteotomies of adult rabbits be successfully ﬁ xed with in- 
 tramedullary SR-PLA96 rods? What are the tissue responses in cortical bone after  
 intramedullary ﬁ xation of a femoral osteotomy with a SR-PLA96 rod? What is the  
 biodegradation rate of the intramedullary SR-PLA96 rods?
3.  Can femoral diaphyseal osteotomies in adult sheep be successfully ﬁ xed by 
 intramedullary SR-PLA96 nails that are interlocked with metallic Kirschner wires? 
 What are the tissue responses to this ﬁ xation?
4.  Can the SR-PLA (70/30) plates together with metallic miniscrews and light-weight 
 external coaptation be used to successfully ﬁ x clinical fractures of the radius and  
 ulna in dogs weighing less than 6 kg? How does the clinical bone healing proceed  
 with this ﬁ xation? What is the clinical biocompatibility of this ﬁ xation in dogs?  
 Do we see development of osteopenia with this ﬁ xation radiographically?
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3.2. Overview of studies
A brief overview of Studies I-IV is presented in Table 5.
3.3. Experimental studies
3.3.1. Implants
Implants studied were made by a self-reinforcing (SR) technique using a poly-L/D-lactic 
acid stereocopolymer with a L/D lactide molar ratio of 96/4. The polymer was obtained 
from PURAC biochem b.v., the Netherlands. Speciﬁ c details of the raw polymer as given 
in the manufacturer’s certiﬁ cate of analysis are shown in Table 6. To prevent extensive 
thermal degradation during processing, water and air were removed from the polymer by 
vacuum drying at 100°C and 0.05 mbar for one day.
Study No.      Species Methods
Experimental
I SR-PLA96 rods in vitro and in 
vivo subcutaneously
24 rabbits Physical measurements of rods
Strength measurements of rods
II Intramedullary SR-PLA96 rods 
in diaphyseal osteotomies
43 rabbits Physical measurements of rods
Strength measurements of rods 
and osteotomies
Radiology and clinical examination
Histology, oxytetracycline ﬂ uores-
cence and microradiography
III Interlocked intramedullary
SR-PLA96 nails in 
diaphyseal osteotomies 
6+3 sheep Radiology and clinical examination
Histology, oxytetracycline ﬂ uores-
cence and microradiography
Clinical
IV SR-PLA (70/30) plates and 
metal screws in ﬁ xation of 
weight-bearing radial fractures
11 toy breed 
dogs
Radiology and clinical examination
Table 5. Overview of Studies I-IV.
Batch number DM362CE
Intrinsic viscosity (dl/g) 8.27
 (in chloroform at 25°C)
Speciﬁ c rotation (in chloroform at 25°C) -143.6
DSC melting range (°C) 143.7-155.1
Heat of fusion (J/g) 39.2
Residual monomer content (%) 0.16
Table 6. Speciﬁ c details of the raw poly-L/D-lactic acid stereocopolymer with a L/D lactide molar ratio of 96/4, used to 
make the biodegradable rods and nails in Studies I- III.
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SR-PLA96 rods
In manufacturing of the rods, the polymer was melt-extruded (Axon BX-15, Sweden) into 
cylindrical billets of Ø 2.7 mm and 11 mm and subsequently die-drawn in a solid state at a 
temperature of 125°C to draw ratios of 5.5 to achieve the SR fi brillated structure in Study 
I. In Study II, the polymer was melt-extruded to rods of Ø 11 mm using a 15 mm extruder 
with temperatures between 178°C and 230°C, the latter being the die temperature. The 
sizes of the fi nished SR-PLA96 rods were Ø 1.1 mm x 30 mm and Ø 4.5 mm x 50 mm 
with rounded ends. The rods were washed with alcohol, dried in a vacuum, packed, and 
sterilized by gamma irradiation at a minimum dose of 2.5 Mrads (actual dose 1.4-1.6 times 
the specifi ed minimum, Kolmi-Set Ltd., Turku, Finland) (Fig. 4).
SR-PLA96 nails
The polymer for the solid nails used in Study III was melt-extruded (Elecster Oy, Finnpack 
TH-20, Finland) into solid cylindrical billets of Ø 22 mm. The billets were then die-drawn 
through a heated conical stainless steel die at a temperature of 125°C to a draw ratio of 5.5 
to achieve the SR fi brillated structure. To improve the transverse strength of the fi brillated 
nail, a fi ber reinforcement layer consisting of melt-spun high-strength PLA96 fi ber (tensile 
strength 500 MPa) of Ø 0.7 mm was fi lament wound in a hoop direction on the surface of 
the drawn PLA96 nail. The fi ber reinforcement was glued on the PLA96 rod by dipping 
the rod into a polymer solution consisting of poly- (L/DL)-lactide (70/30) (Resomer LR 
708, Boehringer Ingelheim Pharma KG, Germany) diluted in acetone. After dipping the 
nails fi ve times into the solution and allowing the acetone to vaporize at room temperature 
between each immersion, the residual acetone was removed by drying in a vacuum oven at 
0.05 mbar for three days. Finally, the other end of the nail was cut and sharpened at a 30° 
angle. After all manufacturing steps, the nails had an outer diameter of 10.66–10.78 mm 
and a length of 195-199 mm (Fig. 5).
Fig. 4. The 4.5 mm self-reinforced poly-96L/4D-lactide (SR-PLA96) rod used in Studies I and II.
Fig. 5. The self-reinforced poly-96L/4D-lactide (SR-PLA96) intramedullary nail of 10.66-10.78 mm in diameter with an oblique 
distal end of 30° used in Study III
SR-PLA96 rod SR-PLA96 nail
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For the pilot study, hollow nails were manufactured by melt-extruding (Elecster Oy, Finn-
pack TH-20, Finland) the polymer into cylindrical tube billets with an outer diameter of 24 
mm and a wall thickness of 3 mm. The tube billets were then die-drawn in the solid state 
at 125°C through a heated conical stainless steel die to a draw ratio of 3.5 to achieve the 
SR partially ﬁ brillated structure. After drawing, the hollow nail had an outer diameter of 
10.2 mm, an inner diameter of approximately 4.5 mm, and a length of 150 mm. The melt-
extruded tube billet was manufactured by using a conventional tube extrusion die with the 
extrusion mandrel centralized within the die with three wing clamps located circumferen-
tially at 120° angular distance to each other. Due to these wings, the melt ﬂ ow was divided 
into three segments within the melt extrusion die. After extrusion, three axial weld lines 
could still be seen in the tube wall. After die drawing, the weld lines remained visible.
In Study III, four Ø 1.5 mm metallic Kirschner (K) wires were used for interlocking the 
nails.
3.3.2. Materials and methods
The numbers of animals and the follow-up times of the experimental studies are shown in 
Table 7. All procedures were approved by the relevant committees of experimental animal 
use.
Number of animals Total
Study Species Follow-up time (weeks)
1 3 6 9 12 14 15 18 24 48 52 78 92 152
Implantation in vivo
subcutaneously (I)
rabbits 3 3 3 3 3 3 3 3 24
Intramedullary nailing of 
femoral osteotomy (II)
rabbits 6 6 6 6 7 5 7 43
Interlocked, intramedullary 
nailing of femoral 
osteotomy (III)
sheep 3 3 6
Pilot study (III) sheep 1 1 1 3
Lost in surgery/anesthesia rabbits 3 3
sheep 5 5
Total number of animals 84
Table 7. Follow-up times of animals in the experimental studies (I, II, III).
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3.3.2.1. Experimental animals and anesthetic procedures
Rabbits
A total of 67 adult rabbits weighing 2.7-4.7 kg (mean 4.0 kg, ± SD 0.37 kg) were used in 
studies I and II.
In the in vivo sc study (I), 15 rabbits received three implants of Ø 4.5 mm and two implants 
of Ø 1.1 mm in the dorsal subcutis. In 9 rabbits, two implants of Ø 4.5 mm and two im-
plants of Ø 1.1 mm were used.
In the in vivo IM study (II), a diaphyseal osteotomy of the femur was ﬁ xed with a SR-
PLA96 rod of Ø 4.5 mm in 43 rabbits.
The rabbits were anesthetized with intramuscular (im) injections of medetomidine (Domi-
tor 1 mg/ml, Orion-Pharma, Turku, Finland) at a dose of 0.5 mg/kg and ketamine hydro-
chloride (Ketalar 50 mg/ml, Parke-Davis, Barcelona, Spain) at a dose of 25 mg/kg. Rabbits 
subjected to osteotomy also received diazepam (Diapam 5 mg/ml, Orion-Pharma, Turku, 
Finland) 0.75 mg/kg as an additional anesthetic agent and buprenorﬁ n (Temgesic 0.3 mg/
ml, Reckitt & Colman, Hall, England) 0.03 mg/kg sc for postoperative analgesia.
Sheep
Femoral diaphyseal osteotomies of adult Finnish Landrace sheep were ﬁ xed with an IM 
SR-PLA96 nail and interlocked with four Ø 1.5 mm K wires. A total of 6 sheep, weighing 
43-63 kg (mean 53.17 kg ± SD 6.74 kg) (sheep #4-9) were used in the study. In the pilot 
study, eight sheep were operated on, but ﬁ ve sheep were lost within days postsurgery due 
to implant failure and anesthetic complications, and thus, were not included in the study. 
The remaining three pilot sheep (sheep #1-3) weighing 57-63kg (mean 60.67 kg ± SD 3.21 
kg) were included in the study for a long-term follow-up.
Food was withheld for 12 hours before surgery, but the sheep had free access to water. 
As premedication the sheep were given 0.5 mg dose of atropin (Atropin 1 mg/ml, Orion-
Pharma, Espoo, Finland) sc and medetomidine 20 µg/kg im. A 17 G cannula (Venoﬂ on 2, 
Viggo, Helsingborg, Sweden) was placed in the cephalic vein. Anesthesia was induced by 
propofol (Diprivan 10 mg/ml, Zeneca Ltd., Macclesﬁ eld, England) 3 mg/kg intravenous-
ly (iv). The sheep were intubated and anesthesia was maintained with 2-2.5% halothane 
(Trothane, I.S.C. Chemicals Ltd., Bristol, England). During surgery 20 ml/kg/hr of ﬂ uids 
(Ringersteril, Medipolar, Oulu, Finland) were administered iv. The sheep were also given 
metronidatzole (Flagyl 5 mg/ml, Rhone-Poulenc Rorer A/S, Birkerod, Denmark) 11 mg/kg 
and benzylpenicillin sodium (Geepenil, Orion-Pharma, Turku, Finland) 35 000 IU/kg iv as 
infection prophylaxis. Postoperatively, benzylpenicillinprocaine/benzathinpenicillin (Dup-
locillin LA, Intervet, Boxmeer, Holland) 35 000 IU/kg sc and phenylbutazone (Reumuzol 
200 mg/ml, Lääkefarmos, Turku, Finland) 8 mg/kg iv were administered once a day for 5 
days.
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3.3.2.2. Operative techniques
Rabbits
The rabbits’ dorsum or knees were shaved and surgically scrubbed with chlorhexidine 
gluconate (Klorhexol 5 mg/ml, Orion-Pharma, Turku, Finland). The rods were inserted 
into the subcutis through small skin incisions in Study I. These were compared to the rods 
in vitro.
In Study II, a lateral parapatellar arthrotomy was made. The patella was dislocated medi-
ally, the muscles of the femur bluntly dissected, and the diaphysis of the femur exposed. A 
Ø 4.5 mm hole was drilled from the intercondylar space at the patellar groove to the med-
ullary canal. A perpendicular cortical bone osteotomy was made with an oscillating saw 
between the middle and the distal third of the femoral diaphysis. The osteotomy was ﬁ xed 
with an intramedullary Ø 4.5 mm SR-PLA96 rod (Fig. 6). The rod was shortened to match 
the shape of the patellar articular surface, if needed. The intact femur served as a control. 
In both Studies (I, II), the incision was closed in layers using absorbable polyglactin 910 
sutures (Vicryl, Ethicon, Nordestedt, Germany). The rabbits were allowed to move freely 
in their cages after the operation with no external support.
Sheep
The right hind leg of the sheep was shaved and scrubbed with chlorhexidine gluconate. The 
femur was approached laterally, and an osteotomy of the mid-diaphysis was achieved with 
an oscillating saw. The medullary canal was reamed open to remove the IM tissue, and a 
hole was created in the trochanteric fossa by retrograde reaming. A small wedge, opening 
cranially, was removed with an oscillating saw from the osteotomy surface in order to 
straighten the curved bone in the 6 sheep (#4-9) of the study. The SR-PLA96 IM nail was 
introduced in a normograde fashion and tapped into the cancellous bone of the distal femur 
until the osteotomy line started to open. The nail was retrograded back slightly and the 
length of the nail was cut with a heated metal blade just before the ﬁ nal tapping into posi-
tion. The K wires were driven transversely through the bone and the nail in an interlocking 
way. Two  1.5 mm K wires were used both proximally and distally to the osteotomy line 
Fig. 6. Schematic anterior (A) and lateral (B) views of the femur showing the 
operative technique with the SR-PLA96 rods in rabbits in Study II.
SR-PLA96
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and placed in different longitudinal planes to prevent longitudinal cracking of the implant 
(Fig. 7). The K wires were cut off about 3 mm from the surface of cortex, and the ends 
were bent along the bone. The intact femur served as a control. Absorbable polyglactin 910 
sutures were used in muscle, fascia, and sc tissues. Skin was closed with polyamide sutures 
(Suturamid, Johnson & Johnson, Brussels, Belgium). The sheep were allowed to recover in 
their own individual pens and to move there freely. No external support was used. 
3.3.2.3. Follow-up times and specimen preparation
SR-PLA96 rods in vitro (I)
The SR-PLA96 rods were immersed in (2.87 g/l) Na2HPO4 (0.67 g/l) NaH2PO4 buffered 
saline (NaCl 5.9 g/l) at pH 7.4 and 0.127 M, and kept at 37°C. Samples were removed from 
the solution at 1, 2, 3, 4, 6, 9, 12, 15, 18, and 24 weeks, and changes in mechanical proper-
ties, crystallinity, and viscosity-average molecular weight (M
v
) were determined.
SR-PLA96 rods in vivo (I, II)
For the in vivo sc study (I), the follow-up times were 1, 3, 6, 9, 12, 15, 18, and 24 weeks. 
After the follow-up time, the rabbits were anesthetized as described above and the rods 
were removed and immersed in 0.9% saline. The implants were tested by the same methods 
as the in vitro implants. A total of 111 SR-PLA96 rods were studied in vivo sc (48 rods of 
Ø 1.1 mm and 63 rods of Ø 4.5 mm). 
In the in vivo IM study (II), the rabbits were radiographed postoperatively, during healing, 
and after sacriﬁ ce. Radiographs were taken in the anteroposterior (target-tube distance 115 
Fig. 7. Schematic anterior view of the femur showing the operative technique with the SR-PLA96 intramedullary nail and sam-
pling for tissue studies in sheep in Study III. The horizontal line in the mid-diaphysis shows the osteotomy site. Four Kirschner
wires 1.5mm in diameter were used to interlock the SR-PLA96 nail. One sample (B) was taken from the area of the osteotomy 
and one sample proximal (A) and one distal (C) to the osteotomy, from a site where a Kirschner wire had been removed. The 
osteotomy site was studied longitudinally (B), and the two other samples (A, C) transversally.
A
B
C
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cm, 48 kV, 6.3 mAs, 0.03 s) and medial to lateral positions (46 kV, 5 mAs, 0.03 s). The 
follow-up times were 3, 6, 12, 24, 48, and 92 weeks and 3 years. Each follow-up group 
consisted of 6 rabbits up till 24 weeks and thereafter of 5-7 rabbits per group. Two rabbits 
from each group were used for strength studies and the rest for histological studies, except 
for the 3-year group, where all rabbits were used for histology. Two days before sacriÞ ce, 
the rabbits were given oxytetracycline (OTC) (Terramycin 50 mg/ml, PÞ zer, Brussels, Bel-
gium) 50 mg/kg im to produce ß uorescence. Rabbits were sacriÞ ced and both femurs were 
harvested. Radiographs were then taken in the anteroposterior and medial to lateral posi-
tions (target-tube distance 115 cm, 40 kV, 4 mAs, 0.03 s). The osteotomy line, the amount 
of callus formation, malpositions, and healing were evaluated in all radiographs. A total of 
31 pairs of femurs were taken for microradiographic, OTC ß uorescence, and histological 
studies. Another 12 pairs of femurs at deÞ ned follow-up times were mechanically tested to 
study the healing of the osteotomy. Both operated and intact femurs were tested. The shear 
strength and, when possible to remove an intact rod from the medulla, the bending strength 
of the rods were also tested.
SR-PLA96 nails in vivo (III)
Healing of the osteotomies was followed both clinically and radiologically. The sheep were 
sedated with medetomidine 20 g/kg im for radiographs, and sedation was reversed with 
atipamezol (Antisedan 5 mg/ml, Orion-Pharmos, Turku, Finland) 100 µg/kg im. Radio-
graphs were taken without a grid in a medial to lateral position with the animal standing 
(target-tube distance 100 cm, 57-66 kV, 12.5 mAs). For OTC-bone labeling, OTC 50 mg/
kg was injected im as a single dose 2 weeks before sacriÞ ce to produce ß uorescence.
The sheep were sacriÞ ced at 6 months (3 sheep) and 12 months (3 sheep). Two sheep 
from the pilot study were euthanized at 14 weeks and 18 months due to health problems (a 
non-union and a pharyngeal tumor, respectively), and one sheep was followed for 3 years. 
After sacriÞ ce, both femurs were harvested and radiographed. The intact femur served as 
a control. Radiographs were taken in the anteroposterior and medial to lateral positions 
(target-tube distance 115 cm, 50 kV, 6.4 mAs). Samples were then sawed from both the 
operated and the control femur for histology, OTC, and microradiography.
3.3.2.4. Examination methods
All equations used for calculation of crystallinity, molecular weight, and strength values 
are shown in original articles I and II.
3.3.2.4.1. Crystallinity and molecular weight measurements (I, II)
A Perkin-Elmer DSC-7 differential scanning calorimeter (DSC) (Perkin-Elmer Co., 
USA), calibrated with indium standards, was used to determine the heat of fusion of intact 
SR-PLA96 rods and after in vitro and in vivo exposure (I, II). The DSC was operated at a 
heating rate of 20°C/min. Dry 6 ± 0.1 mg samples evacuated at room temperature for three 
days were used in each case. The samples were heated in a nitrogen atmosphere from room 
temperature to 200°C (about 50°C above the melting temperature to assure melting of all 
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crystallites), and the heat of fusion was estimated from the area enclosed by the DSC curve 
and the baseline (Migliaresi et al. 1991). The level of crystallinity was estimated from the 
heat of fusion, assuming 93.7 J/g as calculated by Fischer et al. (1973) for perfectly crystal-
line PLLA. Duplicate samples were used in each case.
The solution viscosities (according to American Society for Testing and Materials [ASTM] 
D 445-88) of intact SR-PLA96 rods and after in vitro and in vivo exposure (I, II) were mea-
sured in chloroform at 25°C with an Ubbelohde capillary viscometer (type 0a according to 
ASTM D 446). Inherent viscosities (  in dl/g) in a 0.1% solution (0.1 g/dl) were determined 
as an indication of molecular weight decrease during in vitro and in vivo exposure (Pistner 
et al. 1993b). Mv (in g/mol) was estimated using the Mark-Houwink equation and param-
eters determined by Schindler et al. (1979) for PLLA.
After intramedullary implantation of the SR-PLA96 rods (II), the Mv, the weight-aver-
age molecular weight (Mw), and the number-average molecular weight (Mn) were deter-
mined using gel permeation chromatography, where chloroform was used as the eluent. 
The equipment consisted of a differential refractometer detector (Waters 410 RI), a HPLC 
pump (Waters 515), and three high-resolution columns with 5 mm particle size (Waters 
HR1, HR2, and HR4). The concentration of injected samples was 0.1 mass-%, and the 
injection volume and eluent fl ow rate were 200 ml and 1 ml/min, respectively. Universal 
calibration (k= 5.45*10-4 and a=0.73 for SR-PLA96) was applied using narrow polystyrene 
standards, and the molecular weights were calculated from two parallel injections.
3.3.2.4.2. Strength measurements
In the in vitro and in vivo sc study (I), the bending strength and modulus of the SR-PLA96 
rods were measured by the three-point bending method using a Lloyd 6000R materials 
testing machine (Lloyd Instruments, Fareham, UK) at room temperature (22-23°C) (Fig. 
8). Triplicate samples were tested at each follow-up. The measurements were performed 
on wet samples because drying of the incubated rods leads to a decrease in their strength. 
The support spans and the cross-head speeds were 22 mm and 5 mm/min, and 42 mm and 
10 mm/min, for Ø 1.1 mm and Ø 4.5 mm rods, respectively. The radius of the loading nose 
was 5 mm, and the radius of each support was 1.5 mm.
24 mm
48 mm
F
ROD
Fig. 8. A schematic drawing of the three-point 
bending strength test of the SR-PLA96 rods.
Fig. 9. A schematic drawing of the three-point bending 
strength test of the osteotomy. The dotted line repre-
sents the SR-PLA96 rod inside the bone.
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In the in vivo IM study (II), the SR-PLA96 rods were removed, when possible, from the 
medullary cavity and further tested. The bending and shear tests of the wet rods were per-
formed at room temperature with a Lloyd LR 30K materials testing machine (Lloyd Instru-
ments, Fareham, UK). The bones were tested with the rods, as in most cases it was impos-
sible to release the rod from the medullary cavity without breaking the bone. The bones 
were bent using a three-point bending test where the bone was supported from both ends 
using a support length of 48 mm (Fig. 9). The wet bones were tested at room temperature 
using a Lloyd LR 30K materials testing machine (Lloyd Instruments, Fareham, UK) with 
a testing speed of 10 mm/min. The load needed to break the bone was recorded, and the 
results of the nonoperated and the operated bones of the same rabbit were compared.
The shear strength of the SR-PLA96 rods was measured by means of a tool constructed 
by modifying the standard BS 2782, Method 340B. The tool consisted of two parts, joined 
together by the implant. During the test the parts were pulled apart using a Lloyd 6000R 
materials testing machine operating at a cross-head speed of 10 mm/min. Thus, the im-
plant, resting in a drill hole, was cut into three pieces perpendicularly to the long axis of 
the rod (Fig. 10).
The torsion strength of the Ø 4.5 mm SR-PLA96 rods was measured using the tool shown 
in Fig. 11. One end of the rod was ﬁ xed to a stationary grip, while the other end was turned 
by the rotating grip. The torque was transmitted to the rotating grip by means of a rotating 
wheel and drive shaft mounted to a bearing stand. The test device was connected to a Lloyd 
6000R materials testing machine, and the rotating wheel was turned by a chain attached to 
the load cell at a rate of 0.2 r/min. The load pulling the chain was recorded and used for the 
calculation of torsion strength.
The bending strength of the intact IM SR-PLA96 nails (III) was measured by the four-point 
bending method following the guidelines of ASTM Standard F 383. Tests were performed 
using a Lloyd 6000R materials testing machine (Lloyd Instruments, Fareham, UK) at room 
temperature (22-23°C). Triplicate samples were tested. The support span, the loading span, 
and the cross-head speed were 114 mm, 38 mm, and 10 mm/min, respectively. The radius 
of the rolling supports and the rolling loading points were 5 mm. The bending strength was 
calculated as the bending moment required to produce a permanent deﬂ ection of 0.13 mm. 
The bending moment (in Nm) was calculated by multiplying the force (in N) applied to one 
Fig. 10. Aschematic cross-sectional drawing of the 
shear strength test of the SR-PLA96 rods.
Fig. 11. A schematic drawing of the torsion strength test of the SR-PLA96 
rods.
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of the loading points at a permanent defl ection of 0.13 mm by the distance between loading 
points (= 0.038 m). The force applied to one of the loading points was calculated as half 
of the total force recorded by the load cell of the materials testing machine. The bending 
strength of the solid IM nails used in the study was 28.6 Nm (SD 1.9 Nm) and of the hollow 
IM nails used in the pilot study 22.6 Nm (SD 2.4 Nm), respectively (Fig. 12).
3.3.2.4.3. Histology, oxytetracycline fl uorescence, and microradiography 
The distal halves of the femurs of the rabbits (II) and three samples from the femurs of the 
sheep (III) were sawed from both the operated and the control femur. From the sheep, one 
sample (B) was taken from the area of the osteotomy and the other two samples proximal 
(A) and distal (C) to the osteotomy from a site where a K wire had been removed after har-
vest (Fig. 7). The specimens were fi xed in 70% ethanol and embedded in methylmethacry-
late. For histological analysis, 5- m-thick sections were cut with a microtome (Polycut S; 
Reichert-Jung, Nussloch, Germany) and stained by the Masson-Goldner trichrome meth-
od. For contact microradiography (Faxitron X-ray system, model 43855 A, Hewlett Pack-
ard, McMinnville, OR, USA; Imtec Pol-Edged H.R.P., ultra fl at, type IA, Imtec Products, 
Sunnyvale, CA, USA) and OTC fl uorescence studies, 80-μm sections were cut with a Leitz 
Saw Microtome 1600 (Leitz, Weztlar, Germany). Fluorescence microscopy was performed 
using an HBO 220 ultraviolet lamp (Osram, Berlin, Germany) and a BG 812/6 primary 
fi lter (Leitz). Polarizing microscopy was used to identify birefringent polymeric material 
in the specimens. The osteotomy site was studied longitudinally in both rabbit and sheep 
(sample B), and the two other samples (A, C) from sheep were studied transversally.
3.3.2.4.4. Statistics
In the study I, the effect of time on bending and shear strengths was estimated by fi tting 
regression lines for both in vivo and in vitro experiments. Intercept terms were set equal 
and differences between the slopes were tested. In case of nonsignifi cant in vivo / in vitro 
effect, a common regression line was fi tted. Based on regression models, population mean 
and its 95% confi dence interval (CI) at different times was estimated.
3.3.3. Results
The initial strength values, crystallinity, and viscosity-average molecular weight (Mv) of 
SR-PLA96 rods after gamma irradiation in Studies I and II are shown in Table 8.
Fig. 12. A schematic drawing of the four-point bending 
strength test of the SR-PLA96 nails.
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SR-PLA96 rod
1.1 mm 4.5 mm
Bending strength (MPa) 228 232 (I), 274 (II)
Bending modulus (GPa) 8.4 5.4 (I)
Shear strength (MPa) 152 140 (I), 148 (II)
Torque strength (MPa) - 53 (I)
Crystallinity (%) 38 39 (I), 35.8 (II)
Mv (g/mol) 49 175 53 879 (I),
 65 600 (II)
3.3.3.1. Physical changes in SR-PLA96 rods
The measured changes in inherent viscosity (i.v.), M
v
, and crystallinity of SR-PLA96 rods 
during in vitro and in vivo sc (I) exposure expressed as observed means ± standard devia-
tions (SD), and the molecular weight values and crystallinity of the SR-PLA96 rod in vivo
IM (II) at different follow-up times are presented in Table 9.
Table 9. Changes in physical parameters of SR-PLA96 rods during degradation (I, II).
Follow-up time (weeks)
Rod
diameter
In vitro / in vivo 0 3 6 12 24 48 92
1.1 mm In vitro cryst. (%) 37.9 
(0.08)
38.60
(0.53)
38.70
(1.96)
40.00
(0.08)
46.10
(0.30)
M
v
 (g/mol) 49 175 47 326 42 789 31 602 20 297
i.v. (dl/g) 1.45 
(0.03)
1.41
(0.02)
1.31
(0.03)
1.05
(0.00)
0.76
(0.02)
In vivo sc cryst. (%) 37.9 
(0.08)
35.30
(0.83)
39.00
(2.04)
41.70
(0.08)
47.60
(0.83)
M
v
(g/mol) 49 175 49 640 41 453 32 430 19 207
i.v. (dl/g) 1.45 
(0.03)
1.46
(0.07)
1.28
(0.04)
1.07
(0.05)
0.73
(0.03)
4.5 mm In vitro cryst. (%) 39.0 
(0.35)
35.40
(0.14)
35.30
(0.78)
42.50
(0.71)
48.90
(1.27)
M
v
 (g/mol) 53 879 51 042 48 248 37 945 22 900
i.v. (dl/g) 1.55 
(0.02)
1.49
(0.07)
1.43
(0.18)
1.20
(0.04)
0.83
(0.04)
In vivo sc cryst. (%) 39.0 
(0.35)
35.00
(0.23)
37.90
(0.30)
42.10
(0.08)
46.20
(1.51)
M
v
 (g/mol) 53 879 48 711 47 786 35 796 25 198
i.v. (dl/g) 1.55 
(0.02)
1.44
(0.07)
1.42
(0.02)
1.15
(0.05)
0.89
(0.05)
In vivo IM cryst (%) 35.3 37.1 38.5 39.8 46.6 56.3 68.9
M
v
  (g/mol) 65 600 62 600 54 700 38 600 17 200 2 200 750
M
w
 (g/mol) 72 000 68 400 60 000 42 000 19 500 2 430 796
M
n
 (g/mol) 30 400 30 300 24 600 19 600 2 480 855 438
Table 8. The initial strength values, crystallinity, and viscosity-average molecular weight (Mv) of SR-PLA96 
rods after gamma irradiation in Studies I and II.
sc= subcutaneously; IM= intramedullary; cryst= crystallinity; Mv= viscosity-average molecular weight; Mw= weight-average 
molecular weight; Mn= number-average molecular weight
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3.3.3.2. Strength changes
The measured changes in bending modulus values of the SR-PLA96 rods during in vitro
and in vivo sc exposure expressed as observed means ± SD can be seen in Table 10.
Table 10. Changes in bending modulus values of SR-PLA96 rods during invitro and in vivo subcutaneous (sc) 
exposure. Values are means (± standard deviations) (I)
0 3 6 12 24 weeks
Ø 1.1 mm in vitro 8.4 7.3 7.4 7.1 6.9 GPa
(0.5) (0.3) (0.4) (0.9) (0.2)
Ø 1.1 mm in vivo sc 8.4 6.5 7.6 6.6 6.6 GPa
(0.5) (0.7) (0.6) (0.3) (1.4)
Ø 4.5 mm in vitro 5.4 4.9 5.8 6.6 6.4 GPa
(0.1) (0.1) (0.3) (0.3) (0.3)
Ø 4.5 mm in vivo sc 5.4 5.1 5.9 5.6 6.6 GPa
(0.1) (0.2) (0.5) (0.3) (0.2)
3.3.3.2.1. SR-PLA96 rods Ø 1.1 mm in vitro and in vivo subcutaneously
The measured changes in bending and shear strength values of the Ø 1.1 mm SR-PLA96 
rods during in vitro and in vivo sc exposure expressed as observed means ± SD can be seen 
in Fig. 13. 
The estimated line represents the population mean ± 95% CI of strength values. Bending 
strength decreased fairly linearly with time, and no statistically signiﬁ cant (p=0.5856) dif-
Fig. 13. The strength values of the 1.1 mm SR-PLA96 rods expressed as observed means and standard deviation in vitro and in
vivo subcutaneously (sc). The estimated line represents population mean +/- 95% conﬁ dence interval (CI) of strength values.
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ferences between in vivo and in vitro groups were demonstrated. The decrease in bending 
strength mean ± 95% CI was estimated to be 0.65 ± 0.63 MPa/week (p=0.0437). The base-
line estimate was 208.1 ± 7.8 MPa, and at 24 weeks the population mean ± 95% CI bend-
ing strength was 192.5 ± 10.0 MPa. Shear strength measurements showed no difference 
between in vivo and in vitro exposures (p=0.3803). The mean ± 95% CI rate of decrease 
was minimal, although statistically signiﬁ cant, 0.30 ± 0.22 MPa/week, (p=0.0060). The 
baseline estimate was 148.9 ± 2.6 MPa, and the mean ± 95% CI shear strength at week 24 
was 141.6 ± 3.5 MPa.
3.3.3.2.2. SR-PLA96 rods Ø 4.5 mm in vitro  and in vivo subcutaneously and intramedullarly
The measured changes in bending strength values of the 4.5 mm SR-PLA96 rods during in
vitro and in vivo sc/IM exposure expressed as observed means ± SD can be seen in Fig. 14. 
In the IM study (II), the bending strength of the SR-PLA96 rod was not measured at 3-12 
weeks because the bending force measurement of the osteotomy disturbed the rod. At 24 
weeks, however, the osteotomy site broke separately, and the intact rods could be removed 
from the medullary cavity. At 48 and 92 weeks, the rods were so fragmented that they could 
no longer be removed. 
The measured changes in shear strength values of the Ø 4.5 mm SR-PLA96 rods during in
vitro and in vivo sc /IM exposure expressed as observed means ± SD can be seen in Fig. 
15. In the IM study (II), the shear strength of each rod was measured from the ends of the 
rod (i.e. two separate shear measurements from each studied rod) after bending force mea-
surements and release of the rod from the medullary cavity. The shear strength of the rods 
changed little for the ﬁ rst 24 weeks, but thereafter the rod rapidly lost strength, and at 48 
weeks virtually no shear strength was left (6 MPa). 
Fig. 14. The bending strength values of the 4.5 mm SR-PLA96 rods expressed as observed means and standard deviations in
vitro and in vivo subcutaneously (sc) and intramedullarly (IM). The bending strength value in vivo IM at 24 weeks represents 
mean of two implants
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The measured changes in torsion strength values of the 4.5 mm SR-PLA96 rods during in
vitro and in vivo sc exposure expressed as observed means ± SD can be seen in Fig. 16.
The estimated bending, shear, and torsion strength values of the 4.5 mm SR-PLA96 rods 
during in vitro and in vivo sc exposure are shown in Fig. 17. Estimated line represents the 
population mean ± 95% CI of strength values. Bending strength decreased fairly linearly 
over time, and no statistically signiﬁ cant difference was present between the in vitro and 
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Fig. 15. The shear strength values of the 4.5 mm SR-PLA96 rods expressed as observed means and standard deviations in vitro
and in vivo subcutaneously (sc) and intramedullarly (IM). After the SR-PLA96 rod was used IM for 48 weeks, the shear strength 
was only 6 MPa, i.e. practically no shear strength remained.
Fig. 16. The torsion strength values of the 4.5 mm SR-PLA96 rods expressed as observed means and standard deviations in
vitro and in vivo subcutaneously (sc).
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in vivo sc groups (p=0.7416). The mean rate ± 95% CI of decrease in bending strength 
was 1.72 ± 0.48 MPa/week (p=0.0001). Baseline estimate was 243.5 ± 5.7 MPa, and at 
24 weeks the mean bending strength was estimated to be 202.3 ± 8.0 MPa. Shear strength 
values tended to stay at a higher level longer in vivo sc than in vitro. Because of ﬂ uctuation 
in values from weeks 6 to 18, one common regression line was ﬁ tted. The mean ± 95% CI 
rate of decrease was 0.16 ± 0.18 MPa/week (p=0.0738). Baseline estimate was 136.3 ± 2.1 
MPa, and at 24 weeks 132.4 ± 3.0 MPa. In vitro values of torsion strength were measured 
only till week 12 and torsion strength decreased linearly until this point. The difference in 
torsion strength decline between in vitro and in vivo sc groups just failed to reach statistical 
signiﬁ cance (p=0.0692). One common regression line was ﬁ tted, and the mean ± 95% CI 
rate of decrease was 0.33 ± 0.21 MPa/week (p=0.0015). Based on this model, the mean ± 
95% CI torsion strength at week 12 was 48.1 ± 1.5 MPa. Compared with the baseline esti-
mate of 52.1 ± 1.5 MPa, reduction was minimal during the 12 ﬁ rst weeks. After 12 weeks, 
in vivo strength values decreased rapidly, and the observed mean (± SD) torsion strength at 
week 24 was 27.5 ± 7.5 MPa.
Fig. 17. The estimated lines represent the population means +/- 95% conﬁ dence intervals (CI) of the bending, shear, and torsion 
strength values of the 4.5 mm SR-PLA96 rods in vitro and in vivo subcutaneously.
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3.3.3.2.3. Strength of osteotomy
The bending force required to break the osteotomy and the control bone at different follow-
up times is shown in Fig. 18.
3.3.3.3. Macroscopic and radiological healing of osteotomies
Radiological results of the femoral IM ﬁ xations of cortical bone osteotomies in rabbits (II) 
and in sheep (III) are shown in Table 11 and Figs. 19 and 20.
Table. 11. Radiographical results of the experimental studies (II, III).
Follow-up time (weeks)
3 6 12 24-26 48-52 92 156 Total
Radiographic parameters and parameter class Number of rabbits/sheep 43/6
Osteotomy line
Not visible 0/0 0/0 6/0 6/1 4/3 3/0 6/0 25/4
Slightly visible 0/0 1/0 0/0 0/0 0/1 2/0 0/0 3/1
Clearly visible 6/0 5/0 0/0 0/1 3/0 0/0 1/0 15/1
Callus formation
Slight 6/0 2/0 3/0 6/2 2/3 3/0 4/0 26/5
Moderate 0/0 4/0 3/0 0/1 3/0 2/0 2/0 14/1
Abundant 0/0 0/0 0/0 0/0 2/0 0/0 1/0 3/0
Healing of osteotomy
Good result 6/0 6/0 6/0 6/2 4/3 3/0 6/0 37/5
Malunion 0/0 0/0 0/0 0/0 0/0 1/0 0/0 1/0
Nonunion 0/0 0/0 0/0 0/1 3/0 1/0 1/0 5/1
Fig. 18. The measured bending force (N) required to break the femurs with the osteotomy ﬁ xed with the intramedullary SR-
PLA96 rod, and the control femur. Two specimens were measured at each time point, except at 48 and 92 weeks, where one 
nonunion was excluded in both groups. From 6 weeks onwards, the bending force to break the osteotomy was close to the 
bending force to break the control bone, indicating good healing.
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Rabbits
The ﬁ xations were intraoperatively stable in 23/43 cases, 15/43 had rotational instability 
(RI) and 5/43 experienced an iatrogenic fracture. Of the ﬁ ve iatrogenic fractures, the three 
evident in surgery were ﬁ xed with an osteosuture (PDS, Ethicon, Norderstedt, Germany). 
The immediate postoperative recovery was uneventful in all rabbits. Neither deep bacterial 
wound infections nor macroscopically manifested signs of other inﬂ ammatory reactions at 
the operation site were seen, and all rabbits used their legs within 1-2 weeks.
There were 7/43 rabbits that did not show satisfactory healing. Three of them had RI in-
traoperatively. One malunion resulted from an iatrogenic fracture of the cranial cortex, 
which was ﬁ rst noticed in the postoperative radiographs. Two cases of nonunion were due 
to bone failure: one had an intraoperative fracture (with RI) that was not noticed until the 
postoperative radiographs and therefore an osteosuture was not provided, and the other 
experienced a fracture for an unknown reason 3 weeks postsurgery. Three nonunions were 
due to rod failure. In these cases, the radiographs showed bent rods at 15 weeks in one 
rabbit and at 24 weeks in 2 rabbits (one of these had RI). There was also one rabbit with a 
delayed union (with RI) in the 6-week group. This follow-up time was, however, too short 
to conﬁ rm a nonunion.
Total alignment/zero angulation at the osteotomy was in many cases impossible to achieve 
due to the high variation in the diameter of the medullary canal. This allowed some degree 
of angulation and a small axial step in the cortical alignment at the osteotomy line, often 
evident radiographically immediately after surgery. In evaluating the radiographic results, 
attention was focused on detecting larger axial malalignments, indicating loss of integrity 
of the rods. Therefore, the axial malalignment allowed by medullary variation, i.e. varia-
tion in axial alignment due to a difference in rod diameter compared with the diameter of 
the medullary canal, was deemed acceptable when using an IM pin of ﬁ xed diameter.
*
*
Fig. 19. Radiographs of femoral osteotomies in rabbits 
ﬁ xed with intramedullary SR-PLA96 rods in anteropos-
terior view at 6 weeks, 12 weeks, and 3 years, respec-
tively. The bone shows strong ongoing remodeling at 
3 years. The site of osteotomy is marked with a white 
arrowhead.
Fig. 20. Radiographs of femoral osteotomies in sheep ﬁ xed 
with intramedullary SR-PLA96 nails and interlocking 
metallic Kirschner wires in anteroposterior view at 6 months, 
12 months, and 3 years, respectively. A nonoperated femur 
acting as a control is shown to the far right. The osteotomy 
site (white arrowhead) can still be distinguished at 6 months 
but is difﬁ cult to see thereafter. A thin bone layer (white star) 
encircles the radioluscent implant.
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Sheep
Implant modiﬁ cations and changes in surgical technique were made after the pilot study, 
resulting in healing of 5/6 osteotomies and one nonunion. One sheep (#8) broke a proximal 
K wire at 3 weeks postsurgery and another sheep (#7) a distal K wire at 16 weeks post-
surgery, but both osteotomies still healed. Both proximal K wires of sheep #4 were bent 
at 7 weeks and broken at 12 weeks, but by that time some interdigitating callus had been 
formed and the osteotomy consolidated. The sheep with a nonunion (#6) used the operated 
leg well at 1 week, but at 3 weeks both proximal K wires were broken. The implant was 
bent in radiographs at 9 weeks. However, the sheep used the leg reasonably well and was 
therefore followed.
In the pilot study, there were mechanical problems in the implant design, and some sheep 
were lost within days of surgery due to implant failure. These sheep were not included in 
the study. The remaining pilot sheep were included in order to achieve some longer follow-
ups. Of these three sheep, two healed successfully and were followed long-term (#2-3), but 
one (#1) had a nonunion and was euthanized at 14 weeks. 
The sheep were sacriﬁ ced at 6 months (#4-6), 12 months (#7-9), 18 months (#2), and 3 
years (#3). After sacriﬁ ce, both femurs were harvested. No macroscopic signs of infection 
or inﬂ ammation were present in the healed bones. There was a slight connective tissue 
build-up at the ends of the K wires, and two sheep (#3,9) showed some accumulation of 
connective tissue at the proximal insertion point of the IM nail. Neither reaction inﬂ uenced 
use of the operated leg.
Minor telescoping of the operated bone was shown in one case (#4), where the operated 
femur was 6 mm shorter than the control femur in the anteroposterior view. The two sheep 
from the pilot study (#2,3) that consolidated showed no malalignment or telescoping.
3.3.3.4. Histology, oxytetracycline ﬂ uorescence, and microradiography
SR-PLA96 rods in rabbits 
In the qualitative histological anal-
ysis, only a very mild inﬂ ammatory 
reaction to the implant material was 
seen. In early samples, the implant 
was surrounded by thin sheath 
of connective tissue, and after 12 
weeks by bone. A small amount of 
I
C
B
Fig. 21. A typical mild histological reaction to the 
intramedullary SR-PLA96 rod at 24 weeks. The 
implant (I) is clearly visible and surrounded by 
connective tissue (C) and a thin layer of bone (B) 
(stain, Masson-Goldner, original magniﬁ cation x 
125).
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giant cells and foamy macrophages was seen between 
the implant and the bony capsule (Fig. 21). As the im-
plant degraded and fragmented with time, connective 
tissue invaded the cracks (Fig. 22). When uneventful 
healing occurred, the implant slowly disintegrated and 
the polymer debris was phagocytosed by macrophages. 
At the ﬁ nal follow-up at three years, some giant cells 
and islets of polymer debris, a few millimeters wide, 
were encapsulated by connective tissue and surrounded 
by bone marrow cells (Fig. 23 A and B). However, if 
the implant broke prematurely into larger segments, as 
was seen in nonunions, there was a moderate foreign body reaction, with giant cells and 
lymphocytes at the osteotomy site (Fig. 24).
Microradiographically and histologically, the osteotomies showed bony union between 6 
and 12 weeks. Healing proceeded through slight to moderate callus formation at 6 weeks 
to remodeling from 12 weeks onwards. The drill hole was covered with normal bone tis-
sue and cartilage if the implant was inserted deep under the cartilage surface into the bone 
- otherwise the hole was open or covered with granulation tissue. The implant was frag-
C
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Fig. 23.
A) End-stage degradation of the intramedullary SR-PLA96 rod at 3 
years. D = disintegrated implant material, C = connective tissue, M = 
medullary cells, ma = macrophages loaded with disintegrated implant 
material (stain, Masson-Goldner, original magniﬁ cation x 50).
B) The medulla of the femur is ﬁ lled with normal medullary cells 
(M) and small islets of disintegrated implant material (D) that are visually amorphous and no longer birefringent in polarized light.
The majority of the disintegrated material is surrounded by a connective tissue capsule (C), but scattered macrophages (ma) that
have ingested the material are also seen outside the capsule (stain, Masson-Goldner, original magniﬁ cation x 125).
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Fig. 22. Histology of the intramedullary SR-PLA96 rod at 92 weeks. Small 
amounts of giant cells and foamy macrophages are seen inside the connective 
tissue (C) between the implant (I) and the bony capsule (B) surrounding the 
implant. Medullary cells (M) are seen outside the bony capsule (stain, Masson-
Goldner, original magniﬁ cation x 250).
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Fig. 24. An example of a histological reaction 
to a nonunion at 32 weeks with the SR-PLA96 
rod prematurely degraded. A moderate foreign 
body reaction is seen with accumulation of 
foreign body giant cells (G) in the connec-
tive tissue (C) between the implant (I) and 
the thin layer of bone (B) surrounding the 
implant. Some lymphocytes are also present 
(stain, Masson-Goldner, original magniﬁ ca-
tion x 125).
Fig. 26. Histology showing the end-stage of degradation of the 
intramedullary SR-PLA96 rod at 3 years. The implant has nearly 
disappeared, but breakdown products are still present in small 
amounts. An elliptical island of disintegrated material (D) is seen 
inside the medullary fat (M). Bony walls (B) mark the site of the 
original implant inside the medulla; the diaphyseal cortex is not 
seen in the photomicrograph. An open arrow shows the site of 
magniﬁ cation of Fig. 23 B..
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Fig. 25. Histology of the intramedullary SR-PLA96 rod at 92 
weeks. The implant (I) is still visible, although the stucture has 
started to degrade. Medullary cells (M) are seen outside the 
bone layer (B) lining the implant. Diaphyseal cortical bone (X) 
is seen on both sides. An open arrow shows the site of magni-
ﬁ cation of Fig. 22
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mented from 48 weeks onwards, and the structure started to degrade at 92 weeks (Fig. 
25). At three years, the implant was no longer visible and the medulla was ﬁ lled with bone 
marrow cells and small bony islets together with small amounts of disintegrated, visually 
amorphous implant material (Fig. 26). The thin bone layer that had formed around the im-
plant had begun to dissolve at its proximal end.
The OTC ﬂ uorescence in the operated femur was of high intensity both periosteally and 
endosteally at three weeks and was highest at six weeks at the osteotomy site suggesting 
strong new bone formation. At 12 weeks, minor ﬂ uorescence was present. At 24 and 48 
weeks, ﬂ uorescence was at the same level as in the control femurs, with the exception of 
nonunions, which showed new bone formation inside the callus. At 92 weeks, minor ﬂ uo-
rescence was evident both around the implant and between the old cortex and the bow of 
callus, indicating remodeling. At three years, small areas of ﬂ uorescence were seen inside 
the medulla and along the endosteum.
SR-PLA96 nails in sheep
A nearly identical histological reaction was seen in all three samples (A, B, C) taken from 
the same animal at different locations of the osteotomized femur. The presence of K wires 
induced some formation of connective tissue along their implantation sites (A, C). The 
Fig. 27. Ovine microradiographs taken from the osteotomy site. A mid-diaphyseal osteotomy was ﬁ xed with an intramedullary 
SRPLA96 IM nail and interlocking metallic Kirschner wires. From left to right, the follow-up times of 6 months, 12 months, and 
3 years, respectively, are presented. Anonoperated femur acting as a control is shown to the far right. The osteotomy site (white
arrowhead) can still be distinguished at 6 months but is difﬁ cult to see thereafter. A thin bone layer (white star) encircles the radio-
luscent implant in micrographs.
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Fig. 28. A typical histological reaction to an 
intramedullary SR-PLA96 nail at 6 months 
in an ovine femur. Fragmented pieces of 
implant (I) are surrounded by connective 
tissue (C). Giant cells (G) ingest material 
on the implant surface. Capillaries (CA) are 
being formed in the medulla (stain, Masson-
Goldner, original magniﬁ cation x 125).
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Fig. 31. Aphotomicrograph of an 
intramedullary SR-PLA96 nail in 
an ovine femur at 18 months. Frag-
ments of the implant (I) are distinct 
and bordered by connective tissue 
(C). Medullary capillaries (CA) are 
seen (stain, Masson-Goldner, origi-
nal magniﬁ cation x 250).
Fig. 29. Ahistological picture of an ovine 
femoral nonunion at 6 months with a 
failed intramedullary SR-PLA96 nail. 
Mechanical failure causes the implant 
to degrade prematurely, thus provoking 
a clear foreign body reaction. Numerous 
giant cells (G) and some lymphocytes 
(L) encircle the implant fragments (I). 
Connective tissue (C) is scarce (stain, 
Masson-Goldner, original magniﬁ cation 
x 250).
Fig. 30. A photomicrograph of an ovine femur with 
an intramedullary SR-PLA96 nail at 12 months. 
Broken pieces of implant material (I) are seen sur-
rounded by connective tissue (C). Giant cells (G) 
ingest the slowly degrading material. Only a few 
lymphocytes (L) are seen (stain, Masson-Goldner, 
original magniﬁ cation x 250).
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bony envelope had disappeared from samples B and C at three years but was still seen in 
sample A. No other changes in cell populations were noted compared with different speci-
mens from the same sheep. The only exception to this was the sample from the osteotomy 
site (B) of the individual with a nonunion (#6). However, the two other samples (A, C) 
from this animal were histologically similar to the specimens of other animals in the same 
follow-up group.
Microradiography of the osteotomy site demonstrated both endosteal and periosteal callus 
in the six-month specimen. At 12 months, the bone had remodeled and mainly endosteal 
callus was seen. With longer follow-ups (#2, #3), the osteotomy site was unrecognizable. 
At 6, 12, and 18 months, the implant was enclosed by a thin layer of bone. The bony enve-
lope also encircled the threads around the solid nail. In the three-year follow-up, the bony 
envelope had started to remodel at the osteotomy site, and small islets of bone were seen 
inside the medulla (Fig. 27).
At six months, a very mild reaction to the implant was evident. Two of the osteotomies (#4, 
#5) had united, and a thin layer of connective tissue and/or bone surrounded the implant. 
Some giant cells were seen ingesting the material but number of lymphocytes was scarce. 
The implant material was clearly polarizing (Fig. 28). The sheep with a nonunion (#6) 
demonstrated a clear foreign body reaction, with multinucleated giant cells, foamy macro-
phages, and some lymphocytes at the unstable osteotomy site (Fig. 29).
At 12 months, a bony union was seen in all samples, and the histological picture was quite 
similar to that at 6 months. The osteotomy sites were difﬁ cult to detect. A slightly thicker 
connective tissue layer and a bony envelope were seen around the implant together with 
a few giant cells and foamy macrophages. No accumulations of inﬂ ammatory cells (lym-
phocytes, neutrophils, plasma cells) were noticed. Degrading material was evident in small 
amounts around the samples, but macroscopically the implant was still clearly visible and 
polarizing. A thin layer of bone encircled the thread surrounding the implant (Fig. 30).
One sheep (#2) from the pilot study was followed for 18 months. The implant was still 
Fig. 32.Photomicrographs of an intramedullary SR-PLA96 nail in an ovine femur at 3 years (stain, Masson-Goldner).
A) The medulla is ﬁ lled with disoriented connective tissue (C). Many foamy macrophages (F) but no accumulations of lympho-
cytes are seen (original magniﬁ cation x 250).
B) The disintegrated implant substance (D) is encircled by connective (C) and osteoid (O) tissue. Numerous foamy macrophages 
(F) ingest the degrading material (original magniﬁ cation x 250).
C
FF
C
A
C
D
C
F
O
B
49
visible and polarizing, even though some of the material had disintegrated. The hollow 
implant had separated longitudinally into three pieces, and connective tissue invaded the 
cracks. The osteotomy site could no longer be detected. A connective tissue layer was seen 
between the implant and the bony envelope. A few lymphocytes were present (Fig. 31).
Another sheep (#3) from the pilot study was followed for three years. At this point, the 
implant had macroscopically nearly disappeared and been mainly replaced by disoriented 
connective tissue. No distinct polarization was observed in the samples. Abundant foamy 
macrophages and giant cells were seen on the degrading material, with only a few lympho-
cytes and neutrophils. Some cartilaginous tissue had been formed within the connective 
tissue. Small bony islets were seen inside the medulla aligned by active osteoblasts. The 
bony envelope had disappeared from the osteotomy site but was still visible in the proximal 
sample (Fig. 32A. and B).
OTC ﬂ uorescence was identical between the operated bones and the control bones, with 
the exception of the nonunion and the three-year samples. The nonunion showed enhanced 
uptake in the periosteal callus, suggestive of new bone formation. At three years, small 
islets of ﬂ uorescence were seen inside the medulla, indicating remodeling of bone tissue.
3.4. Clinical study
3.4.1. Implants
The SR-PLA (70/30) plates were made of a poly-L/D-lactic acid stereocopolymer with a L/
DL isomere ratio of 70/30 (Boehringer Ingelheim, Ingelheim, Germany). The inherent vis-
cosity of the raw material was 6.3 dl/g. The amorphous material was extruded, and the SR-
PLA (70/30) implants were manufactured by the die-drawing method with a draw ratio of 
three (Bionx Implants Ltd., Tampere, Finland). The implants were gamma-sterilized with 
a minimum dose of 2.5 Mrad (Willy Rüsch AG, Kernen, Germany). The mid-diaphyseal 
(MD) plates were 50-70 mm x 7 mm (length x width). The distal (D) plates were conical, 
conforming to the shape of the distal radius, and had dimensions of 35-55 mm x 7-9 mm, 
respectively. The plates were 1 mm thick and had no predrilled holes (Fig. 33).
Arbeitsgemeinschaft für Osteosynthesefragen (AO) metallic miniscrews of Ø 1.5-2.0 mm 
were used (Stratec Medical, Oberdorf, Switzerland) (Fig. 33).
Fig. 33. The biodegradable SR-PLA (70/30) plates used 
for ﬁ xation of radial/ulnar fractures in toy breed dogs are 
shown next to a metallic mini T-plate and a 10 mm x 2.0 
mm miniscrew (in the middle). The conical SR-PLA (70/30) 
plate used on distal fractures is shown below. The middi-
aphyseal plate is similar to the straight commercial SR-PLA 
(70/30) plate shown on top, except that no premade screw 
holes exist.
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3.4.2. Materials and methods
3.4.2.1. Patient description
A total of 11 toy breed dogs (mean bodyweight 3.1 kg; range 1.6-5.4 kg) were operated on. 
Signalment of the dogs is shown in Table 12. All dogs had sustained an acute, unilateral ra-
dial/ulnar fracture within 3 days of surgical repair. Using a mediolateral radiographic view, 
the distance between the distal end of the radius and the main fracture line was measured, 
and the result expressed as a percentage of the total length of the radius from the distal (0%) 
to the proximal (100%) end (Muir 1997). Seven dogs had distal (range 13–24%) and four 
had mid-diaphyseal (range 34–66%) antebrachial fractures.
Table 12. Case signalment of 11 toy breed dogs with radial/ulnar fractures 
ﬁ xed with SR-PLA (70/30) plates and metallic miniscrews (IV)
Case # Age Gender Breed Weight (kg) Cause of trauma
1. 1 y F Medium poodle 5.4 Stumbled on stairs
2. 10 mo F Toy poodle 2.6 Fell from lap
3. 6 y F Italian greyhound 2.7 Played with another dog
4. 8 mo M Bichon bolognese 2.7 Home alone
5. 9 mo F Italian greyhound-Miniature 
pincher mix
5.3 Fell from lap
6. 1 y M Moscow miniature terrier 1.7 Home alone
7. 4 y F Pomeranian 2.5 Fell from lap
8. 4 mo M Kleinspitz 3.3 Played with kids
9. 4 y F Italian greyhound 4.3 Home alone
10. 6 mo M Toy poodle 2.4 Fell from bed
11. 6 mo M Pomeranian 1.6 Home alone
3.4.2.2. Operative techniques
Dogs were sedated with medetomidine (Domitor® 1 mg/ml, Orion Pharma, Turku, Finland) 
40 µg/kg im. All dogs received perioperative cephalotin (Keﬂ in® 1 g, Lilly, IN, USA) 20 
mg/kg, meloxicam (Metacam , Boehringer Ingelheim Vetmedica, Germany) 0.2 mg/kg, 
and buprenorﬁ n (Temgesic  0.3 mg/ml, Schering-Plough, Brussels, Belgium) 0.01 mg/kg 
iv. Anesthesia was induced by propofol (Rapinovet  10 mg/ml, Schering- Plough, Farum, 
Denmark) 1-2 mg/kg iv and maintained by 1.5–2% isoﬂ urane (IsoFlo , Abbott Animal 
Health, Queenborough, Great Britain). Dogs were monitored by electrocardiogram, cap-
nometry, and pulse oximetry throughout the surgery. Body temperature was maintained 
using a heated water cushion.
Standard surgical technique for repair of radial/ulnar fractures was used. The sterile plate 
was placed over the reduced fracture and the sites for screw holes were marked on the plate, 
and the length and width of the plate was estimated according to the available bone. At 
least 3 screws were required on each side of the fracture line. The plate was then trimmed 
with scissors, and the cut edges were smoothed with a ﬁ le. Screw holes corresponding to 
the outer diameter of screws (1.5 or 2.0 mm) were drilled in the plate. Depressions to coun-
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tersink screw heads in the plate were made with a 3.2 drill bit. In 6 dogs, two plates were 
stacked symmetrically over the fracture to provide increased stiffness. The outer plate was 
usually a few screw holes shorter than the underlying plate. The neutralization plating then 
proceeded according to the established AO protocol. After fracture ﬁ xation, a cancellous 
graft was harvested from the ipsilateral humerus or ilium. The wound was closed with 3-0 
polyglycolic acid (Saﬁ l®, Braun, Tuttlingen, Germany) and 3-0 monoﬁ lament polyamide 
(Daﬁ lon®, Braun, Tuttlingen, Germany) sutures. Postoperative analgesia was provided by 
meloxicam solution 0.1 mg/kg once daily orally for 3-10 days. Cephalexin (Kefavet  solu-
tion 50 mg/ml, Orion Pharma, Turku, Finland) 25 mg/kg twice daily was administered for 
10 days orally if soft tissue injuries were present.
Light-weight external coaptation was used in all dogs until bridging callus was detected 
or the radial fracture line was not evident on radiographs. Splint materials (presented in 
Table 13.) were chosen based on the size of the dog and the degree of radial consolidation. 
Coaptation was changed every two weeks and continually reduced during healing.
3.4.2.3. Follow-up studies
The dogs were followed clinically and radiographically at 2, 4, 6, 9, 12, and 24-26 weeks 
and at 1 and 2 years. The puppies (#8, #10, #11) were controlled only until consolidation of 
the fracture line was seen, then at 24-26 weeks and long-term. Comparison radiographs of 
the contralateral antebrachium were taken at 26 weeks and at 1 and 2 years.
Time of full weight-bearing on the leg was recorded. Soft tissues overlying the implant 
were palpated at rechecks in order to detect abnormal tissue reactions. Range of motion 
of the adjacent joints and size of the prescapular lymph node were compared to the con-
tralateral side. Radiographs were evaluated for malpositions, and signs of osteopenia or 
bone reactions under the plate. Time of complete radial radiographical consolidation was 
recorded. Radial callus formation was calculated by measuring the largest callus forma-
tion seen on any postoperative radiograph and reported as fraction of bone diameter at the 
fracture site. Primary union was assigned a value of 0%.
Owners were interviewed by phone 3 years postsurgery to evaluate the long-term tissue 
tolerance of the implants (limb use, licking or possible soft tissue reactions over the im-
plant area).
3.4.3. Results
Type of fracture, methods of ﬁ xation and external coaptation, type of radial callus forma-
tion, and time of consolidation together with possible complications and long-term out-
come of patients are presented in Table 13.
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Table 13. Method of treatment and outcome of radial/ulnar fractures in toy breed 
dogs ﬁ xed with the SR-PLA (70/30) plates and metallic miniscrews (IV).
Case # Type of 
fracture *
Fixation ** Graft External 
coaptation ***
WB
§
RC
§§
Callus
§§§
Complications
during healing
Outcome
and  clinical 
follow-up
time
1. MD (66%) MD plate 70x7 
mm; doubled
Yes Soft splint 3 wk 12 
wk
21% - Excellent; 2 y
Comminuted on fracture site 
and adjacent 
9 wk Carried a litter 
2 y postop
2 screws; 3/3 
screws
2. Distal (23%) D plate 45x7 mm; Yes Soft splint 2 wk 10 
wk
8% - Excellent; 2 y
Transverse 4/3 screws 7 wk Carried a litter 
1 y postop
3. Distal (20%) D plate 45x7 mm; Yes Soft splint 4 wk, 2 wk 12 
wk
9% - Fracture 
through a 
screw site at 1 
y > euthanasia
Short oblique 4/4 screws then Q tip splint
 4 wk > 8 wk
4. Distal (24%) MD plate 70x7 
mm; doubled 
Yes Spoon splint 4 
wk, then WTD 
splint
2 wk 6 wk 8% - Excellent; 2 y
Transverse on fracture site 
and adjacent
2 wk > 6 wk
2 screws; 4/3 
screws
5. Distal (13%) D plate 55x7 mm; Yes Soft splint 6 wk 2 wk 9 wk 0% - Excellent; 2 y
Transverse 5/3 screws
6. Distal (16%) D plate 35x7 mm; Yes WTD/Q tip 
splint 6 wk
1 wk 9 wk 0% - Excellent; 2 y
Short oblique 3/3 screws
7. MD (40%) MD plate 50x7 
mm;
Yes Q tip splint - - - Plate failure Implant 
failure
Transverse 4/3 screws at 4 wk Died at 
reoperation
8. Distal (21%) D plate 55x7 mm; 
doubled
Yes Q tip splint 
2 wk
1 wk 4 wk 14% - Excellent; 2 y
Transverse  with MD plate on 
4 most
 distal screws; 4/2 
screws
9. Distal (17%) MD plate 70x7 
mm; doubled
Yes WTD/Q tip 
splint 6 wk + 
carpal ﬂ exion
9 wk 14 
wk
43% Skin problems 
from screws and 
splint
Ambulation
excellent
but visible 
screw heads 
> implant 
removal
at 1 y
Short oblique  on 6 most distal 
screws;
 for 1 wk > 7 wk
5/3 screws
10. MD (34%) MD plates 70x7 
and 50x7 mm;
Yes WTD splint 
4 wk
2 wk 9 wk 17% Recurrent small 
skin wound
Excellent,
skin normal; 
Short oblique doubled on 7 most 
distal
2 y
screws; 5/3 screws
11. MD (46%) Double MD plates 
50x7 mm; 
No Q tip splint 
4 wk
2 wk 12 
wk
36% - Excellent; 2 y
Short oblique 4/3 screws 
* MD = mid-diaphyseal; fracture site reported as % of radial length / ** D =distal; number of screws proximal/distal to the fracture line 
*** Buster soft splint or spoon splint, WTD = wooden tongue depressor/ § WB = time of full weight-bearing on the leg/ §§ RC = time of complete 
radiographical radial consolidation / §§§ Callus calculated by measuring the largest callus formation seen on any postoperative radiograph and reported 
as a fraction of bone diameter at the fracture site. Primary union received a numeral value of 0 %
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No intraoperative complications occurred. Fracture reduction was adequate and repairs 
were seemingly stable before wound closure. Immediate postoperative radiographic evalu-
ation indicated good reduction in all dogs. Most dogs were using the repaired limb continu-
osly by 2 weeks. Mean external coaptation time was 6 weeks. Fracture healing occurred in 
10/11 dogs; and in most dogs the fracture line had almost disappeared between the 6- and 
9-week recheck examinations (Fig. 34 and 35). Complete radial healing was typically seen 
by 9-12 weeks. Mean callus formation was 15.6%.
A CB D
Fig. 34. Radiographs of a distal radial/ulnar fracture ﬁ xed with a distal SR-PLA (70/30) plate and metallic 2.0 mm miniscrews 
taken postoperatively (A, B) and at 10 weeks (C, D).
A B C D
Fig. 35. Radiographs of a mid-diaphyseal radial/ulnar fracture ﬁ xed with two middiaphyseal SR-PLA (70/30) plates and metallic 
1.5 mm miniscrews taken postoperatively (A, B) and at 9 weeks (C, D).
54
A single plate failure was noticed in one 
dog at the 4-week control (#7). Unfor-
tunately, asystole occurred during seda-
tion for surgical correction. Resuscita-
tion was unsuccessful and necropsy conﬁ rmed sudden cardiac arrest. The plate had failed 
transversely at the mid-diaphyseal fracture site.
Metal screws were palpable through the skin in all dogs during follow-up. This was not 
a problem except in an Italian greyhound (#9) that had extensive skin bruising from the 
original trauma and further skin problems because of external coaptation at the initial re-
check examination. As a result of the thin scar tissue, some screw heads appeared through 
the skin intermittently, and all screws were eventually removed, together with the subse-
quently loose SR-PLA (70/30) plates, one year postoperatively. Aerobic bacterial culture 
from the wound was negative. The plates were brittle and broken into 2-3 pieces. No ab-
normal bone reaction was observed on radiographs at any time and the use of the leg was 
normal in this dog.
A B C D
Fig. 37. Radiographs of a distal radial/ulnar fracture, taken 6 months after ﬁ xation with a metal plate (A) and after removal of 
the metal plate 9 months postsurgery (B). The bone was refractured 5 months after plate removal and the dog was admitted to 
this study. Radiograph C was taken 6 months after ﬁ xation with a distal SR-PLA (70/30) plate and metallic miniscrews. The con-
tralateral antebrachium is shown as a control (D). No signs of osteopenia are seen after plating with the biodegradable SR-PLA 
(70/30) plate.
Fig. 36. Cytology from a small recurrent skin wound at 
the operation site after ﬁ xation with two mid-diaphyseal 
SR-PLA (70/30) plates and metallic 1.5 mm miniscrews 
(dog #10). A mild inﬂ ammatory reaction with some 
neutrophils, small polylactide particles, and occasional 
macrophages was seen. Neither accumulations of foamy 
macrophages, giant cells, nor lymphocytes indicating a 
foreign body reaction were noted (stain, May-Grünwald-
Giemsa, original magniﬁ cation x 1250).
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One Toy poodle (#10) developed a small skin wound at the operation scar on 4 occasions 
(6 weeks, and 6, 9, and 15 months). Some implant-induced skin tension occurred at the 
wound area and the owner reported on 2 occasions that mechanical trauma from brush-
ing this area resulted in an open wound. The wound was revised and a visible screw and a 
small piece of protruding plate were removed. On cytology of the wound ﬂ uid, there was 
a mild inﬂ ammatory reaction with neutrophils, some polylactide particles, and occasional 
macrophages (Fig. 36). There was no cytological evidence of a foreign body reaction to the 
implant material and subsequent recovery was uneventful.
The other Italian greyhound (#3), who had already suffered two fractures at the same loca-
tion before entering this study, fractured the antebrachium for the third time one year fol-
lowing the SR-PLA (70/30) ﬁ xation. This fracture occurred through a screw site proximal 
to the original fracture site. The owner declined further surgery and the dog was eutha-
nized. An inﬂ uencing factor could be that the 2.0 mm metal screw occupied 36% of the 
radial diameter after the bone diameter had diminished by 21 % from the original diameter 
during the previous metal plating.
The SR-PLA (70/30) plates were no longer palpable at 2 years except in one dog (#4). No 
subcutaneous swelling or discomfort associated with degradation of the plates was ob-
served. No abnormal bone reactions were seen on long-term radiographs. Owners reported 
normal limb use and no adverse soft tissue reactions were noted during the 3 years after 
surgical repair.
No radiographic signs of osteopenia were observed at any time under the SR-PLA (70/30) 
plates (Fig. 37) even though some loss of bone density was evident in metacarpal and car-
pal bones in 4 dogs after splint removal. No malpositions or functional problems of the leg 
were seen. Range of motion of adjacent joints and size of the prescapular lymph nodes was 
evaluated as normal in all dogs.
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5. DISCUSSION
Physical properties
The molecular weight of the SR-PLA96 rods began to decrease as soon as the rods were 
implanted, and reduction was fastest intramedullarly when the implants were stressed in
vivo. After 24 weeks, the rods in vitro showed 60%, the sc rods 50% and the IM rods less 
than 30% of the initial value. Decrease in molecular weight is the ﬁ rst sign of degradation 
before changes in strength values or macroscopic appearance are seen (Reed and Gilding 
1981, Bos et al. 1988, Matsusue et al. 1992). The molecular weight of implants made of 
SR-PLA96 decreased slower than those made of nonreinforced PLA96 indicating slower 
degradation (Cordewener et al. 1995).
The crystallinity of the SR-PLA96 polymer increased over time both in vitro and in vivo in 
this study. High crystallinity is probably one of the factors that makes PLLA particles very 
stable and resistant to hydrolysis, and the even more crystalline polymer residue that forms 
during degradation of these implants has been thought to cause late foreign body reactions 
(Bergsma et al. 1995b, Cordewener et al. 1995). Although the crystallinity of PLA96 in 
our studies increased, it remained substantially lower than the crystallinity of pure PLLA, 
a ﬁ nding also reported previously (Kulkarni et al. 1971, Bergsma et al. 1995c). Lower 
crystallinity results in enhanced degradation of PLA96 as compared with 100% PLLA and 
may also diminish the risk of late foreign body reactions.
Strength properties
The initial strength values of the SR-PLA96 rods were quite comparable with or even 
higher than those of pure SR-PLLA rods used in ﬁ xation of cortical osteotomies in rab-
bits (Majola et al. 1992b, Manninen and Pohjonen 1993). The strength values showed a 
temporary decline at 1-3 weeks but then rose back to the original level. This decline is 
likely the result of softening of the rods due to absorption of water and body ﬂ uids, with 
the subsequent strength increase occurring as the crystallinity of the rods increases. At 12 
weeks, the bending strength remained close to the initial value, and at 24 weeks was still at 
the level of the cortical bone (Swanson 1971). The shear strength did not change markedly 
during the ﬁ rst 24 weeks, but the torsion strength declined by half. The bending modulus 
values stayed at the level of the cortical bone throughout the follow-up, hence avoiding 
the risk of implant-induced stress shielding. Thus, somewhat surprisingly, our ﬁ brillated, 
self-reinforced stereocopolymer rods maintained their strength even longer in vivo than 
did the previously mentioned sintered or ﬁ brillated SR-PLLA rods (Majola et al. 1992a, 
Manninen and Pohjonen 1993). A complete loss of mechanical properties of nonreinforced, 
as-polymerized PLA96 has been reported after just seven weeks (Cordewener et al. 1995), 
and the strength properties of stereocopolymers are usually lost faster than those of homo-
polymers (Majola et al. 1992a). The implants in the present study were manufactured by 
the SR technique, which results in a substantial increase in strength values for polylactide 
implants (Törmälä et al.1988, 1990). Experimental studies and a review by Zhang et al. 
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(1996) have shown that the purity of the polymer is possibly the most critical factor affect-
ing the degradation rate of polylactides. Use of a well-characterized commercial medical 
grade polymer, carefully puriﬁ ed from a residual monomer, enhanced the strength retention 
of the SR-PLA96 rods in the present study.
We found no statistically signiﬁ cant differences in the strength retention of SR-PLA96 rods 
between in vitro and in vivo sc groups during the ﬁ rst 24 weeks. This is in accordance with 
many previous studies and suggests degradation due to hydrolysis (Leenslag et al. 1987b, 
Bos et al. 1988, Matsusue et al. 1992, Cordewener et al. 1995). Faster loss of strength in
vivo, due to cellular enzymes and stress-cracking, has been reported when the implants have 
been dynamically loaded (Williams 1981, Vasenius et al. 1990, Suuronen et al. 1992). Still, 
the subcutaneous model was chosen for the in vivo study in the ﬁ rst phase, as no statisti-
cally signiﬁ cant differences have been observed in the strength retention of self-reinforced 
osteosynthesis rods in the bone compared with subcutaneous tissue (Vasenius et al. 1990, 
Majola et al. 1992a). Our results support this observation; the reduction in strength values 
in the in vivo sc study was quite similar to that of the rods in in vivo IM study. However, 
after six months, the SR-PLA96 rods rapidly lost their strength intramedullarly and at one 
year practically no shear strength remained. This is ideal for the healing of the osteotomy 
and the gradual shift of weight-bearing onto the healing bone.
Healing of diaphyseal osteotomies and fractures
The overall healing results of the experimental and clinical studies were quite sat-
isfactory as 83-84% of the femoral ﬁ xations and 91% of the radial ﬁ xations con-
solidated without malunion. Implant failures were seen in 3/43 rabbits, 1/6 sheep, 
and 1/11 dogs. The bending force needed to break the osteotomy in the rabbit study 
depended solely on the rod itself at 3 weeks, but thereafter it was close to the bend-
ing force needed to break the control bone, indicating good healing. 
We had only one size of IM rods and nails available in both IM studies. This al-
lowed some axial stepping, particularly in the rabbits, but also in the relatively 
curved ovine femurs if the K wires were set parallel. Fixing a transverse osteotomy 
of the femur with a single IM nail is challenging as the rotational forces are not 
prevented by this ﬁ xation. This was also veriﬁ ed in our rabbit study, as many of 
the osteotomies were rotationally unstable in surgery. However, swelling of the 
polylactide implant due to body ﬂ uids and having an elastic modulus close to bone 
create friction between the polylactide rod and the bone and enhance stability at 
the osteotomy site (Viljanen et al. 1998, 2001).
All of the healed osteotomies in our rabbit study had only slight to moderate callus forma-
tion, indicating fairly stable ﬁ xation. In the sheep study, solid nails, with a strong rein-
forcement ﬁ ber of the same material wrapped around the implant, and interlocking were 
required for proper healing, as hollow nails or early failure of both proximal K wires re-
sulted in implant failure. The latter might have been avoided by using K wires of larger 
diameter but that would have made bending the ends of the wires difﬁ cult. In the clinical 
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study of the radial/ulnar fractures in toy breed dogs, fractures healed in 4-14 weeks. The 
healing rate was comparable and the complication rate similar to or lower than in studies in 
which metal plates (Larsen et al. 1999) or external ﬁ xators (Haas et al. 2003) were used to 
treat radial/ulnar fractures in toy breed dogs. Overall, results indicate that self-reinforced 
implants are quite stable and stress resistant even when they are made of copolymers of 
polylactide stereoisomers.
Operative techniques
One of the advantages of polymer implants is the possibility of intraoperatively molding 
the implant. The thin SR-PLA (70/30) plates can be cut with scissors to ﬁ t the length and 
width of the bone, and they also allow individual selection for screw sites and bending 
without heating. On the distal radial fractures in toy breed dogs, we were able to place 3-4 
screws even on the smallest fragments, compared with standard AO miniplates or T-plates, 
where applying more than 2 screws to very small distal fragments is difﬁ cult. However, 
in our experience, the SR-PLA96 rods cannot be shaved to ﬁ t a narrow-diameter medulla. 
Severing the rod surface breaks the outer lining and destroys the ﬁ brous ultrastructure of 
the rod by delamination, hastening hydrolysis. 
Metallic K wires and screws were used with biodegradable nails and plates to study only 
one biodegradable component at a time. The K wires did not appear to affect the use of 
the operated leg in sheep even when they caused some local tissue damage. Interlocking 
of a PLLA IM nail with PLLA rods has been successfully carried out in sheep by van der 
Elst et al. (1999), but it required use of a guide wire system and continuous radiological 
imaging. Our aim was to study operative techniques that could be performed with standard 
veterinary orthopedic equipment.
Biocompatibility
The SR-PLA96 rods and nails were well tolerated and did not induce any signiﬁ cant histo-
logical reactions, even during ﬁ nal degradation, if the osteotomy healed uneventfully and 
degradation of the implant occurred slowly. However, when the degradation was prema-
turely accelerated by a mechanical failure, i.e. nonunion, the SR-PLA96 material provoked 
a moderate FBR accompanied by some lymphocytes signaling a mild inﬂ ammation. When 
the material degrades, the histological response seems to depend on the size of the foreign 
material particles. Small particles are phagocytosed by macrophages, whereas giant cells 
surround the bigger fragments. When the mass of the material is very large, as with IM 
nails, it is ﬁ rst isolated with connective tissue and/or bone before the degradation process 
begins.
The ﬁ nal degradation in the rabbits was fairly subdued, whereas many foamy macrophages 
ingesting the disintegrated material were noted at the three-year follow-up in sheep, sug-
gesting a histologically recognizable, albeit a subclinical, controlled FBR. Severe FBRs 
with large numbers of lymphocytes were reported 2.5 years after femoral osteotomies in 
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sheep were successfully ﬁ xed with as-polymerized PLLA and PLLA/PGA implants (Van 
der Elst et al. 1999). The authors speculated that polymeric implants of large volume could 
therefore involve greater risks for repulsion. Interestingly, Bergsma et al. (1995c) sug-
gested that smaller PLA96 particles could even evoke a more intense histological response 
than PLLA. However, no accumulations of lymphocytes or neutrophils indicative of an 
immunological inﬂ ammatory reaction in addition to a FBR were noted in the present study. 
Still, the end-stage degradation of these large implants should be experimentally examined 
in a bigger population before their use in clinical ﬁ xations.
No macroscopic ﬂ uid accumulations or sinus formations during degradation were seen in 
the present study. The skin problems observed in two dogs with stacked SR-PLA (70/30) 
plates were evaluated to be mainly due to skin tension induced by the mass of the implants. 
They were assessed not to be due to absorbed implant material, as there was a history of 
local trauma to the skin and no cytological support for a FBR or an association with the 
degradation time of the implant. Similar skin problems have been reported in toy breed 
dogs when metal plates have been used for ﬁ xation of radial/ulnar fractures (Larsen et al.
1999). A more medial surgical approach could have diminished the skin problems.
FBRs have been reported extremely rarely in animals compared with man, which could be 
due to species differences or to overly short follow-ups in most experimental animal stud-
ies. Räihä et al. (1990,1992) described ﬂ uid accumulations in two dogs 7-8 weeks after a 
SR-PDLLA/PLLA (50/50) screw ﬁ xation, and local bone loss in two cats 24 weeks after 
an IM SR-PLLA stack pinning ﬁ xation. These reactions occurred prior to ﬁ nal degradation 
of these implants and their cause remained unclear, but in both cases there was evidence of 
premature implant failure and instability at the osteotomy site. For dogs or cats receiving 
PLA implants, no follow-up studies reporting long-term biocompatibility could be found in 
the literature by the author. Tunc et al. (1983,1985) stated in a congress report that implan-
tation of PLLA plugs and rods in canine tibia was biocompatible at two years, when most 
of the PLLA was absorbed (see review of Vainionpää et al. 1989). Also, none of the owners 
of some 100 dogs and cats receiving self-reinforced biodegradable implants in the clinical 
studies of Räihä et al. (1993a,b,c) or during the last 10 years at the Espoo Animal Hospital, 
Espoo, Finland, have contacted the hospital for problems associated with late FBRs to the 
implants (J Räihä, 2004, pers.comm.).
A recent article reported late tissue reactions, manifested as small palpable masses, also 
with SR-PLLA screw ﬁ xations of the ankle in man 8-11 years postsurgically (Voutilainen 
et al. 2002a). Shattered particles of birefringent PLLA, multinucleated giant cells, ﬁ bro-
cytes and macrophages were seen in histology. When totally absorbable SR-PLA (70/30) 
plate ﬁ xation in radial/ulnar fractures of toy breed dogs is studied, the absorbable screws 
should also be made of stereocopolymers of SR-PLA to decrease the risk for late FBR 
when PLA implants are used on top of the bone. Assemblies where both screws and plates 
are made of SR-PLA (70/30) are already in clinical use in human plastic and maxillofacial 
surgery, and SR-PLA (70/30) screws have shown no complications during a 2- year follow-
up after arthrodesis in man (Voutilainen et al. 2002b).
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Degradation
The SR-PLA96 rods disappeared almost totally within the 3-year follow-up, as evaluated 
histologically and under a polarizing light. PLLA implants made of pure L-lactide seem 
to degrade quite slowly, over a number of years, depending on the size and the anatomic 
location of the implant. Although intraosseous degradation of SR-PLLA rods and screws in 
ankle fractures and arthrodesis in man was demonstrated in a recent study at 4-5 years, the 
implant channels still showed incomplete bony ingrowth (Voutilainen et al. 2002). Stereo-
copolymeric IM SR-PLA (60/40) implants, by contrast, showed the ﬁ rst signs of degrada-
tion at 12 weeks, and by 4.5 years the implants had disappeared and been replaced by can-
cellous bone in rabbits and rats (Majola 1995). This enhanced biodegradation is expected, 
as copolymers of L-lactide with D- or DL-lactide have a faster breakdown rate than 100% 
PLLA (Christel et al. 1983, Bergsma et al. 1995a,c). The SR-PLA (70/30) plates used in 
Study IV were expected to degrade within 2-3 years (Pohjonen and Törmälä 1996). Only 
one plate was still palpable after 2 years. A more reliable, noninvasive evaluation concern-
ing degradation of PLA implants in a clinical environment could have been achieved by 
MRI or CT, which was not possible in this study (Pihlajamäki et al. 1997, Voutilainen et al.
2002). When a small osteotomy of the femoral condyle in sheep was secured with 2.0 mm 
PLA (70/30) pins, no implant material was left and the pin channels were ﬁ lled with either 
cancellous bone or scar tissue at 3 years (Prokop et al. 2004).
Osteopenia
No radiographic signs of osteopenia were observed in bone under the SR-PLA (70/30) 
plate at any time in toy breed dogs in the present study. This was as expected as the elastic 
modulus of the SR-PLA (70/30) implants is close to that of bone and the strength of the im-
plants gradually decreases in 18-36 weeks, transferring the load to the healing bone during 
biodegradation of the plate (Pohjonen and Törmälä 1997a). Implant-induced osteoporosis 
has a multifactorial pathogenesis, with the early-onset osteonecrosis being elicited mainly 
through cortical vascular insufﬁ ciency due to the original injury, open fracture ﬁ xation, 
and plate-induced compression. Later, stress protection caused by the excessive rigidity 
of the metal implants compared with bone may also contribute to the development of os-
teoporosis (Field 1997, Viljanen et al. 1998, 2001). Although a study on long-term plate 
application for ﬁ xation of radial fractures in dogs reported no signiﬁ cant differences in ra-
dial cortical bone density more than one year after plating, toy breed dogs frequently show 
signs of bone resorption when metallic implants or external coaptation are used (Waters et
al. 1993, Glennon et al. 1994, Haas et al. 2003).  Use of polylactide implants in ﬁ xation 
of femoral osteotomies maintained cortical thickness and cortical bone density at almost 
normal levels, whereas the metal-ﬁ xed femurs showed signiﬁ cantly lower density values, 
indicating stress protection by the metallic ﬁ xation (Hanafusa et al. 1995, Viljanen et al.
1998, 2001).
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Clinical relevance
The biodegradable implants here are not suggested to replace but to complement the use of 
traditional metallic implants in cortical bone ﬁ xation. The higher purchase price of absorb-
able implants is offset by no need for implant removal surgery, thus also avoiding the asso-
ciated risks, and pain, which is very important to our animal patients and their owners. The 
IM SR-PLA96 rods can be recommended for ﬁ xation of femoral diaphyseal fractures in 
small dogs and cats when some interdigitation of the fracture ends is present.   The SR-PLA 
(70/30) plates together with metallic screws and light external coaptation can be considered 
as an alternative to metal plates for radial fracture repair in toy breed dogs, however avail-
able plates are likely not strong enough when used as a single plate. As the bioabsorbable 
polymers can act as carriers to deliver different substances to the bone (Calhoun and Mader 
1997, Heckman et al. 1999), a specially designed biodegradable plate with enhanced stiff-
ness that is combined with an osteostimulatory substance and ﬁ xed with absorbable screws 
could be a novel solution for ﬁ xation of radial fractures in toy breed dogs in the future.
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6. CONCLUSIONS
Based on these studies, the following conclusions can be drawn:
1. The changes in crystallinity and molecular weight values indicated faster degradation of 
SR-PLA96 than of pure SR-PLLA. No signiﬁ cant differences were found in the strength 
retention of SR-PLA96 rods between in vitro and in vivo sc groups. Strength values and 
strength retention of these SR stereocopolymer rods were found to be comparable or even 
higher than those of pure SR-PLLA rods. Both bending and shear strength values stayed 
above the level of cortical bone for 24 weeks. The strength properties of the SR-PLA96 
rods were deemed to be adequate for ﬁ xation of diaphyseal osteotomies in rabbits.
2. Using SR-PLA96 rods, uneventful ﬁ xation/healing of femoral diaphyseal osteotomies 
occurred in 36/43 rabbits (84%). From 6 weeks onward, the bending force needed to 
break the osteotomy was comparable with the force needed to break the control bone. 
The biocompatibility of the rods was very good, even during end-stage degradation. Only 
in nonunions, where the implant was fragmented prematurely, a FBR was induced. The 
SR-PLA96 rod disappeared almost totally from the femoral medulla within the 3-year fol-
low-up. SR-PLA96 rods were concluded to be suitable for IM ﬁ xation of femoral cortical 
osteotomies in adult rabbits.
3. Solid SR-PLA96 nails with a ﬁ ber reinforcement layer and interlocking were required 
for succesfull ﬁ xation in sheep. Femoral consolidation was seen in 5/6 (83%) sheep. Bio-
compatibility of the large SR-PLA96 nails was very good at 6-18 months, when the im-
plant was macroscopically still intact. One nonunion with an implant failure showed a 
FBR. In one sheep followed for 3-years, an almost disintegrated implant and a considerable 
but controlled FBR to the implant without an inﬂ ammatory component were seen. The SR-
PLA96 nails interlocked with metallic Kirschner wires show potential for ﬁ xing femoral 
diaphyseal osteotomies in adult sheep. The long-term tissue response towards such large 
implants should, however, be studied in a larger population before these implants are taken 
into clinical use.
4. Amorphous SR-PLA (70/30) plates together with metallic miniscrews and light external 
coaptation were deemed suitable for ﬁ xing clinical radial/ulnar fractures in toy breed dogs 
as 10/11 (91%) fractures healed without malpositions. Bone healing was evident on radio-
graphs from 4 to 14 weeks. Healing and complication rates after repair of radial fractures 
with SR-PLA (70/30) plates were considered similar or better than reported after repair 
with metallic plates or external ﬁ xation in toy breed dogs. Most of the SR-PLA (70/30) 
plates were no longer palpable at 2 years, and their degradation was not associated with any 
clinically apparent FBRs. No radiographic signs of osteopenia were identiﬁ ed under the 
plate during follow-up. Biodegradable polylactide plates can be considered as an alterna-
tive to metal plates for radial fracture repair in toy breed dogs, however available plates are 
likely not strong enough when used as a single plate.
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